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CHAPTER I 
INTRODUCTION 
High serum cholesterol levels are associated with the development of coronary 
heart disease, the leading cause of death in the United States (62, 73, 74, 98). However, 
cholesterol is an essential component of the human body because it is a precursor to 
vitamin D, steroid hormones, and bile acids. It also helps maintain the fluidity of cellular 
membranes. 
Studies have indicated that some lactobacilli can remove cholesterol from 
laboratory media and have the potential to reduce serum cholesterol levels in humans (7, 
15, 40). While studying the Maasai warriors, Mann and Spoerry (79) found that 
fermented milk may have a hypocholesterlemic effect in humans. Other studies have 
revealed that certain strains of lactobacilli have a cholesterol lowering effect in humans 
(5, 50, 80, 81) and animals (15, 16, 18, 40, 47, 86, 103, 123, 133). 
The mechanisms involved in removal of cholesterol from laboratory media and 
lowering serum cholesterol levels in animals and humans are not well understood. 
Klayver and Van der Meer ( 65) said that removal of cholesterol from laboratory media 
during growth of L. acidophilus was due to deconjugation of bile salts resulting in 
disruption of the cholesterol micelles and "coprecipitation" of the cholesterol with the 
free bile acids. Deconjugated bile acids are less soluble as the pH drops due to acid 
production during growth by the cultures (111). However, Noh and Gilliland (92) grew 
cultures of L. acidophilus at a constant pH of 6.0. They found that cholesterol was still 
removed from the broth and that some of the cholesterol was recovered in the cellular 
membrane of the organisms thus indicating that the cells actually assimilated cholesterol. 
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Either mechanism can result in lowering of serum cholesterol levels. Any 
cholesterol assimilated by the lactobacilli in the small intestine would not be available for 
absorption into the blood by the human. Also, deconjugation of a large amount of bile 
salts by the culture could indirectly lead to lower serum cholesterol levels. 
The most important route of excretion of cholesterol from the body is through the 
excretion of bile acids (127). Bile acids are synthesized in the liver from cholesterol and 
then they are conjugated with glycine or taurine and secreted into the small intestine 
where some of them may undergo deconjugation. Lactobacilli have been identified as the 
bacterial species most heavily involved in deconjuation of bile acids in the small 
intestines (13, 17, 36, 66, 75, 114). When bile acids are deconjugated in the small 
intestine, they are more readily excreted than conjugated ones (93). Cholesterol from the 
body is used to replace the bile acids that are excreted thus reducing the amount of 
cholesterol in the body. 
When animals are fed bacterial cultures which have high bile salt hydrolase 
activity, there are more bile acids excreted in the feces and thus the serum cholesterol 
levels are reduced (11, 122). 
Buck and Gilliland (7) isolated several strains of lactobacilli from human 
volunteers in an effort to discover a strain(s) having great potential for controlling serum 
cholesterol in man. One strain of L. acidophilus that was isolated removed a very large 
amount of cholesterol from laboratory media during growth. A study at the University of 
Kentucky revealed that hypercholesterolemic persons who consumed this strain of L. 
acidophilus had significant reductions in their serum cholesterol levels (unpublished). 
The strain is currently used to manufacture a yogurt product sold in Holland. The 
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product is sold making the claim that it can help maintain desirable serum cholesterol 
levels. 
The objective of this study was to determine if L. acidophilus and L. casei 
removed cholesterol from laboratory media in a similar manner by 1) determining if there 
was a difference in the amount of cholesterol removed from the laboratory media when 
the pH was maintained at a constant level (pH 6.0) compared to cells grown without pH 
control, 2) determining the amount of sodium taurocholate deconjugated by the cultures 
during growth with and without pH control, and 3) determining if L. casei prefers to 
deconjugate sodium glycocholate or sodium taurocholate during growth with and without 
pH control of the medium at pH 6.0. 
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CHAPTER II 
REVIEW OF LITERATURE 
Significance of Cholesterol Assimilation by the Lactobacilli 
Role of Cholesterol in the Body 
Cholesterol is an essential component of the human body. It is a precursor to 
steroid hormones, Vitamin D and bile acids and is important in maintaining the fluidity of 
cell membranes (127). However, deposition of excess cholesterol in the arteries can lead 
to coronary heart disease, the leading cause of death in the United States (62, 73, 98, 
124). 
The body's cholesterol is synthesized in the liver and/or is absorbed from dietary 
sources from the intestinal tract (3, 22, 31, 83, 121 ). The most important route of 
excretion of cholesterol from the body is through the bile acids. Bile acids are 
synthesized from cholesterol in the liver and are then conjugated with glycine or taurine 
before they are excreted into the small intestine. The bile acids act as emulsifiers to aid 
in the digestion of fats. Most bile acids are recirculated via enterohepatic circulation and 
are reused. Enterohepatic circulation involves recycling of the bile acids through the 
liver and intestinal tract by absorbing them and excreting them again and again. Bile 
acids deconjugated in the small intestines are more likely to be excreted via the feces than 
are conjugated ones. Conjugated bile acids are more readily absorbed from the small 
intestine than are deconjugated ones. Less than 1 gram/day of bile acids is excreted. 
Cholesterol is then converted to more bile acids to replace the excreted ones. According 
to Voet and Voet (127), this is the only route for excretion of cholesterol from the body. 
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Relationship between Cholesterol and Coronary Heart Disease 
Coronary heart disease is the leading cause of death in the United States (62, 73, 
98, 124). Arteriosclerosis is associated with high levels of low density lipoproteins 
(LDL) in the blood and is the major cause of coronary heart disease (60, 124). 
Atherosclerosis, the most common form of arteriosclerosis, is characterized by a 
thickening of the inner wall of the arteries. The arterial thickening is due to the 
deposition of lipids and cholesterol in the arterial walls. The deposits become calcified 
and narrow the openings of the arteries and cause the formation of blood clots thus 
restricting blood flow to the heart. When blood flow is blocked to the heart, myocardial 
infarctions (heart attacks) occur (127). 
The best example of the relationship between cholesterol and coronary heart 
disease is familial hypercholesterolemia. This is an inherited disease that is characterized 
by a high level of cholesterol rich, circulating LDL's in the blood which cause cholesterol 
levels that are 3-5 times higher than normal (127). Persons with this condition develop 
atherosclerosis at an early age because of the large amounts of cholesterol in the body. 
Cells in the body are unable to utilize the cholesterol in the LDL's because they lack LDL 
receptors so the body must make all the cholesterol needed. Death usually occurs within 
the first 20 years of life due to coronary heart disease directly related to the high plasma 
LDL levels. 
Studies have shown that in persons with primary hypercholesterolemia, lowering 
the plasma cholesterol levels and LDL cholesterol can reduce the chances of developing 
coronary heart disease (73, 74). Several methods have been studied to lower serum 
cholesterol levels. 
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Methods to Control Serum Cholesterol Levels 
About 50% of blood cholesterol is absorbed from dietary and biliary cholesterol 
in the intestinal tract (11, 20, 21, 94). A study by Conner et. al. (14) reported that there is 
a positive correlation between dietary cholesterol intake and serum cholesterol levels. 
This data suggests that the serum cholesterol levels can be controlled somewhat through 
dietary modifications. 
Additionally, there are drugs available to aid in lowering serum cholesterol 
levels. Most of these drugs inhibit the production of cholesterol by the liver or bind bile 
acids thus increasing their secretion. There are some undesirable side effects including 
constipation, heartburn and nausea associated with the drugs (73). Cholestyramine, a 
drug proven to be effective in lowering serum cholesterol levels (73, 74), is a bi_le acid 
sequesterant that causes excess excretion of bile acids. However, this drug and others 
that function in a similar manner interfere with the absorption of fats and fat-soluble 
vitamins (97). Dujovne (24) reported that using a combination of Probucol with 
Colestipol was effective in lowering the serum cholesterol levels from 242 +/- 51 to 171 
+/- 41. The combination of the two drugs resulted in fewer physical side effects. 
However, the undesirable side effects and health risks associated with drugs justify the 
need for alternative ways to lower serum cholesterol levels. 
Van Belle (126) proposed four methods to increase fecal excretion of bile acids 
and thus lower serum cholesterol levels; 1) alter the oxidation of cholesterol in the liver 
so that it will be converted to bile acids and thus excreted, 2) use drugs to cause 
production of bile acids by the liver that are not easily reabsorbed, 3) use drugs that 
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inhibit the reabsorption of bile acids from the liver, and 4) alter the intestinal micro flora 
to favor the growth of organisms that actively deconjugate bile acids thus increasing their 
excretion. 
A paper by Grundy and Bilheimer ( 46) also suggested several approaches to 
reducing serum cholesterol levels. The first approach was a dietary change to reduce the 
amount of cholesterol in the diet. Secondly, synthesis of cholesterol by the body could be 
inhibited by various drugs. Last of all, they suggest reducing the absorption of 
cholesterol from the small intestine. None of the authors suggested specific approaches 
for their suggestions. 
Role of Gut Microflora in Controlling Serum Cholesterol Levels 
Excretion of bile acids via the feces is the primary means of elimination of 
cholesterol from the body (78, 127). Eyssen (28) reported that the intestinal microflora 
play a major role in interfering with the reabsoprtion of bile acids from the intestine thus 
promoting their excretion. He studied both conventional and germ free chicks fed a diet 
high in cholesterol. The germ free chicks had serum cholesterol levels twice as high as 
the conventional animals. Additionally, the germ free chicks excreted significantly less 
cholesterol and bile acids than the conventional chicks. 
In another study, Chikai et al. (10) inoculated germ free rats individually with 
either Bacteroides vulgatus, Bifidobacterium longum, Clostridium ramosum or 
Escherichia coli. Following inoculation they were fed a normal diet. Excretion of bile 
acids increased in all the rats except those inoculated with E. coli. E. coli does not 
deconjugate bile acids. Also, more of the bile acids that were excreted in the inoculated 
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animals were deconjugated compared to the bile acids excreted by the germ free rats. 
They reported that free bile acids are excreted more readily than conjugated ones. 
Additionally they speculated that bile acids may bind to microorganisms and/or dietary 
fiber in the intestinal tract thus leading to excretion. 
Effect of Cultured and Culture Containing Dairy Products on Serum Cholesterol Levels 
There are many health benefits associated with lactic acid bacteria (29). Many 
studies have indicated that cultured or culture containing dairy products may lower serum 
cholesterol levels. Mann and Spoerry (79) were the first to report this phenomenon. 
While studying the Maasai tribesmen in Africa, they discovered that after the tribesmen 
consumed large quantities of milk fermented with a "wild" strain of Lactobacillus they 
had reduced serum cholesterol levels. As part of a tribal ritual, the tribesmen consumed 
the fermented milk for six days and then slaughtered and ate a steer on the seventh day. 
The ritual was continued for three weeks. The researchers supplemented the milk 
consumed by one half of the men with Tween 20, a surfactant that was thought to 
enhance lipid absorption and the other half of the men served as a control by drinking 
milk supplemented with olive oil. In both groups there was an increase in weight, but a 
decrease in serum cholesterol levels. The researchers' original hypothesis was that the 
men who consumed the Tween 20 would have higher serum cholesterol levels than the 
control group due to the increased absorption of cholesterol. The results were contrary to 
the hypothesis and they concluded that there was some component in the fermented milk 
that lowered the serum cholesterol levels of the tribesmen. 
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Mann (80, 81) continued to study the effect of fermented milk on serum 
cholesterol levels. He evaluated the serum cholesterol levels of persons who consumed 
either whole milk fermented with commercial yogurt cultures or nonfermented milk for 
twelve days. The group that consumed the fermented milk had significant reductions 
serum cholesterol levels after the twelve day study. Similarly, a study by Thakur and 
Jha (123) reported a reduction in serum cholesterol levels in rabbits who were fed yogurt. 
Bazzarre et al. (5) studied the effect of yogurt on high density lipoproteins (HDL) 
and serum cholesterol levels of women. They found that there was a significant decline 
in serum cholesterol levels in the women who consumed yogurt compared to women who 
did not consume yogurt. Also, the HDL cholesterol:total cholesterol ratio was higher for 
the women who consumed yogurt compared to those who did not. 
Rao et al. (103) Studied the effects of milk fermented with Streptococcus 
thermophilus on the serum cholesterol levels of rats compared to rats fed a diet 
supplemented with skim milk or water. The rats fed the fermented milk had significantly 
lower serum cholesterol levels than those who did not receive the fermented milk. They 
also evaluated the methanol solubles in both fermented and nonfermented milk. They 
found that feeding rats the methanol solubles from the fermented milk significantly 
lowered serum cholesterol levels while the solubles from the nonfermented milk did not. 
They speculated that the metabolites produced during fermentation may be responsible 
for the hypocholesterolemic effect. Similarly, a study by Thakur and Jha (123) reported 
that rabbits who were fed a high cholesterol diet supplemented with yogurt had lower 
serum cholesterol levels than rabbits fed a similar diet supplemented with milk. Over 
time, the cholesterol levels of rats fed a diet supplemented with the milk did not decline. 
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The researchers suggested that calcium might be involved. However, Howard and Marks 
(55) found that a diet supplemented with calcium gluconate daily for 7 days did not affect 
serum cholesterol levels. This suggests that calcium may not be involved in the 
hypocholesterolemic effect. 
Hepner et al. (51) studied the effect of both pasteurized and nonpasteurized yogurt 
on serum cholesterol levels. After 12 weeks of the trial, they found that both yogurts 
significantly reduced serum cholesterol levels in humans compared to those who 
consumed 2% milk. Because the culture was inactive in the pasteurized yogurt, these 
authors concluded that the active culture may not be involved in the hypocholesterolemic 
effect. 
Some studies report that there is no effect of cultured dairy products on serum 
cholesterol levels. Thompson et al (125) evaluated the effect of sweet acidophilus milk, 
yogurt, skim milk and 2% fat milk on serum cholesterol levels. Sixty eight individuals 
consumed the dairy products for nine weeks and there was no significant effect on their 
serum cholesterol levels. It is important to note that these individuals were not 
hypercholesterolemic and they were not consuming any excess dietary cholesterol during 
the study. 
A study by Jaspers et al. (59) reported that yogurt consumption had no effect on 
total cholesterol, HDL cholesterol, LDL cholesterol, serum lipoproteins, and serum 
triglycerides in human males. The total serum cholesterol levels decreased for the first 
14 days but then returned to normal after 21 days. Lin et al (71) studied a commercially 
available product which contains L. acidophilus ATCC 4962 and L. delbrueckii subsp. 
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bulgaricus ATCC 33409. They found that it had no effect on the concentrations of serum 
lipoproteins in humans. 
Similarly, Pulsani and Rao (102) reported that there was no effect on serum 
cholesterol levels in rats fed milk fermented with either L. acidophilus, S. thermophilus 
or L. bulgaricus. A study by Modler et al. (85) reported that there was no relationship 
between consumption of Bifidobacteria and reduction of serum cholesterol levels. 
Conversely, a study by Kiyosawa et al. (64) found that skim milk was more 
hypocholesterolemic that yogurt on serum cholesterol levels in male rabbits. Two other 
studies found similar results in humans (56, 108). Both studies reported that the lower 
serum cholesterol levels in humans was probably due to the lower lipid content of skim 
milk compared to yogurt. 
Several studies have reported that various naturally occurring substances in 
bovine milk inhibit cholesterol synthesis in the body. Uric and orotic acid, and 3-
hydroxy-3-methylglutarate (HMG) are among the substances identified by many 
researchers (1, 26, 49, 81, 95). A study by Haggerty et al. (48) reported that the amount 
of orotic acid in bovine milk declined during yogurt fermentation. Conversely, Ferriera 
(30) found that there was no decrease in the amount of orotic acid in bovine milk during 
yogurt fermentation. The differences may be due to strain differences in the starter 
culture used for making the yogurt. However, these results indicate that some factor 
other than the orotic acid could be responsible for the hypocholesterolemic effect of 
yogurt. 
In these studies the researchers did not report the strain of the culture or if it was 
viable or able to assimilate cholesterol. It is possible that the culture used for the 
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production of the cultured product was not viable when consumed or was not a strain that 
assimilated cholesterol. Additionally, the researchers did not determine if the 
microorganisms actually survived and grew in the digestive system. The researchers also 
did not specifically select host-specific strains for their studies. All of these criteria can 
play a role in the potential hypocholesterolemic effect of various cultures. The lack of 
focus on these areas could be the explanation for the inconsistency in the results from one 
study to another. 
A study conducted by Imaizumi et al. (58) illustrates this point. They studied the 
effect of whey collected from cultured skim milk on the secretion of bile acids by 
cultured hepatocytes. The differences in the amount of bile acids secreted was more 
dependent on the strain of bacteria used to culture the milk than on the species. Both L. 
casei 2230 and Bifidobacterium longum 2912 increased the activity of7 a-hydroxylase, 
the enzyme responsible for the rate limiting step in conversion of cholesterol to bile 
acids. Stimulation of the enzyme by the two strains resulted in increased secretion of bile 
acids. 
Hypocholesterolemic Activities of Lactobacillus acidophilus and L. casei 
Lactobacilli are part of the normal microflora of the intestinal tract of humans. 
The lactobacilli help in inhibiting the growth of pathogenic bacteria and aid in the 
digestion process (2, 27). Many researchers have studied the effect of L. acidophilus on 
assimilation of cholesterol in vitro and on the effect of serum cholesterol levels in 
humans and animals. 
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Mott et al. (86) studied germ free rats who were inoculated with Lactobacillus 
acidophilus. Following inoculation, the rats were either allowed to develop a normal 
intestinal flora or not allowed to develop it. The rats who were allowed to develop a 
normal intestinal flora had significantly lower serum cholesterol levels than those who, 
because of being kept in sterile chambers, did not develop the normal flora. The 
excretion of bile acids by rats in the nonsterile environment was lower than that of the 
rats in the sterile environment. From these results, the researchers suggested that 
microbial deconjugation alone was not the only factor effecting the serum cholesterol 
levels. They suggested that microbial metabolism of cholesterol might play a possible 
role. 
Zacconi et al. (133) reported that mice who had L. acidophilus in their intestinal 
tracts showed a reduction in serum cholesterol levels compared to rats who did not have 
L. acidophilus. Similarly, Danielson and Gustaffson (16) reported that germ-free rats had 
higher serum cholesterol· levels than rats that have normal intestinal flora. In another 
study, Thakur and Jha (123) reported that normal and cecetomized laying hens had 
significantly lower serum cholesterol levels after consuming L. acidophilus for one 
month. 
Harrison and Peat (50) studied the serum cholesterol levels of newborn infants. 
They reported that human infants fed milk containing L. acidophilus has significantly 
lower serum cholesterol levels, greater weight gain, and more lactobacilli in their stools 
than infants fed sterile milk. A study by Robins-Browne et al. (106) also reported that 
humans excreted more lactobacilli in their stool after consumption of a commercial 
product containing L. acidophilus than did persons not consuming the product. 
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Grunewald (47) reported that rats who consumed milk fermented withL. 
acidophilus had significantly lower serum cholesterol levels compared to rats who 
consumed only milk. 
Gilliland et al. ( 40) reported that L. acidophilus assimilated cholesterol in vitro. 
When the culture was grown under anaerobic conditions in the presence of bile, it 
removed cholesterol from the growth medium. They evaluated several strains of L. 
acidophilus originally isolated from pigs. They grew the cells in MRS broth and used a 
pleuropneumonia-like organism (PPLO) serum :fraction as the source of cholesterol. The 
cultures were grown at 3 7°C and the cells were removed from the broth by centrifugation. 
There was less cholesterol in the spent broth compared to uninoculated broth. There was 
variation depending on the strain of L. acidophilus. L. acidophilus strain RP32 ( currently 
named ATCC 43121) which took up significantly more cholesterol than other strains, 
was fed to pigs fed a high cholesterol diet. After 10 days, the serum cholesterol levels in 
the pigs fed a diet supplemented with L. acidophilus RP32 were significantly lower than 
the levels of the pigs fed a high cholesterol diet with no added L. acidophilus. L. 
acidophilus strain P47, also isolated from a pig, did not assimilate cholesterol in vitro. It 
was also fed to pigs fed a high cholesterol diet. The serum cholesterol levels of these 
pigs were not significantly different from the control. 
Danielson et al. (16) also isolated several strains of L. acidophilus from adult 
boars. They found that strain 16 was very active in removal of cholesterol from broth in 
vitro. They made yogurt with this strain and fed it to boars who were fed a high 
cholesterol diet for 56 days. The boars who received the L. acidophilus strain 16 had 
significantly lower serum cholesterol levels compared to the controls. 
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Another study (61, 119) reported that the bacteria responsible for eye formation in 
swiss cheese, Propionibacteriumjreudenreichii, removed at least 50% of the cholesterol 
present in the PPLO form in the growth medium. The cholesterol removed from the 
broth was recovered with the bacterial cells. 
In a recent study, Buck and Gilliland (7) isolated L. acidophilus (7) and L. casei 
(8) from human volunteers. They found variation in the isolates with regard to the 
amount of cholesterol assimilated from laboratory media. They suggested using the 
strain that assimilated the most cholesterol and were the most bile tolerant for dietary 
adjuncts to reduce serum cholesterol levels in humans. 
The strain isolated by Buck and Gilliland was used in a human study at the 
University of Kentucky. Diets ofhypercholesterolemic individuals were supplemented 
with L. acidophilus LI. Individuals who received the L. acidophilus LI had significant 
reductions in their serum cholesterol levels (not published data). This isolate is currently 
used in a yogurt drink called Fhysiq in Holland. In Holland the product is sold making 
the claim that the yogurt drink can help maintain a desirable serum cholesterol level. 
De Rodas et al. (18) studied the effect of feeding diets supplemented with L. 
acidophilus ATCC 43121 and calcium on pigs with hypercholesterolemia induced by 
diet. They reported that pigs fed a diet supplemented with L. acidophilus had serum 
cholesterol levels 11.8% lower than the pigs fed a diet containing no L. acidophilus. 
Similarly, pigs fed diets containing 1.4% calcium had lower serum cholesterol levels than 
those fed .7% calcium. Additionally, serum bile acids were lower in the pigs fed theL. 
acidophilus and the 1.4% calcium compared to controls. This data suggests that strains 
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of L. acidophilus that actively assimilate cholesterol in vitro may also lower serum 
cholesterol levels in vivo. 
A study by Klaver and Van der Meer ( 65) reported that the "assumed assimilation 
of cholesterol" was due to the "coprecipitation" of the cholesterol with the bile salts. Bile 
salts are deconjugated by the bacteria and the deconjugated bile salts tend to precipitate 
as the pH of the growth medium drops below pH 6.0. They suggested that the cells do 
not actually take up the cholesterol. Also, Reynier et al. (105) reported that 
deconjugated bile salts affected the solubility of cholesterol. 
Conversely, Walker and Gilliland (128) evaluated 19 strains of L. acidophilus for 
bile salt deconjugation, cholesterol assimilation, and their ability to grow in the presence 
of bile. The cultures reached maximum deconjugation activity and cholesterol 
assimilation in the late exponential phase of growth when they were grown in MRS broth 
supplemented with sodium taurocholate and cholesterol micelles . However, there were 
no significant statistical correlations between cholesterol assimilation and the 
deconjugation of bile salts .. 
Additionally, a study by Noh and Gilliland (91) determined that cholesterol 
assimilated by L. acidophilus was not metabolically degraded by the cells during growth 
in MRS broth. They recovered cholesterol removed from the MRS broth in the 
membranes of the cells of L. acidophilus. They also reported that cholesterol was 
assimilated during growth at pH 6.0. Cells grown in the presence of cholesterol were 
more resistant to lysis by sonication than those grown without cholesterol further 
suggesting that growth in the presence of the cholesterol altered the cell wall and/or the 
cellular membrane making the cells more resistant to lysis. 
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Bile Salt Deconjugation by the Lactobacilli 
Absorption of Lipids from the Small Intestine 
Lipids, including cholesterol and other sterols, triglycerides, free fatty acids and 
fat soluble vitamins, require bile acids for absorption from the small intestine (9, 13, 53, 
54, 77). The bile salts act as emulsifiers that help solubulize lipids in the intestinal tract. 
The bile salts are amphiphatic and form a micellular structure around the lipids so they 
can cross the intestinal mucosal cells. Studies by Gallo-Torres et al. (33) and Holt (54) 
reported that conjugated bile acids formed better micellular structures with lipids than 
deconjugated ones. Therefore, the conjugated bile acids are better at facilitating the 
absorption of lipids including cholesterol. They also reported that taurocholic acid better 
facilitated lipid absorption than glycocholic acids. However, there is very little taurine in 
the diet so glycocholic acid predominates in the intestinal tract of humans (23). 
The vast majority of cholesterol uptake occurs in the upper two-thirds of the 
intestines (25). Holt reported that 2 mM "critical mi cellular concentration" of bile acids 
is required in the intestinal tract for proper lipid absorption. When conjugated bile acids 
are present in the intestinal tract at concentrations less than 2 mM, cholesterol may not be 
' 
absorbed from the small intestine {33). 
Role oflntestinal Microorganisms in Bile Salt Deconjugation 
The intestinal microorganisms metabolize bile acids and cholesterol in the 
intestinal tract. Various metabolites are formed which alter the biological and 
physiological functions of the bile acids and cholesterol (57). Among the various 
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metabolites formed are dehydroxylation products of the bile acid nucleus and 
epimerization of hydroxyl groups of C3, C6 and C1 of the steroid ring in cholesterol. 
Jonsson et al. (61) studied microbial bile acid transformation in healthy infants. 
They reported that 55-63% of the bile acids in the meconium were conjugated with 
taurine while only 11-32% were conjugated with glycine. However, by one month of 
age, the majority of bile acids appearing in the feces were deconjugated. The amount of 
deconjugated bile acids appeared in conjunction with establishment of the intestinal 
microflora. Among the conjugated bile acids present in the one month olds, glycine 
conjugated bile acids were present in higher amounts compared to the taurine conjugated 
ones. 
The enzyme bile salt hydrolase is responsible for the deconjugation of bile acids 
by the intestinal microflora. Several researchers have studied this enzyme and a number 
of microorganisms have bile salt hydrolase activity. The genera Lactobacillus(I3, 17, 35, 
66, 75, 114), Bacteroides (IO, 84, 114, 120), Bifidobacterium (IO, 82, 114) 
Fusobacterium (19, 66) Clostridium (44, 82, 84, 88), Peptostreptococcus (19, 66), and 
Streptococcus (66, 114) have the ability to deconjugate bile acids through the production 
of bile salt hydro lase. 
Many studies have reported that there is variation in bile salt hydrolase activity 
among strains of Lactobacillus. Kobashi et al. (66) reported that there also was variation 
among species in preferences of the bile acids. They found that L. fermentum 
deconjugated both glycocholate and taurocholate, while L. brevis and L. plantarum would 
deconjugate glycocholate only. They found that L. xylosus deconjugated taurocholate 
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while L. acidophilus and L. leichmanni did not deconjugate either glycocholate or 
taurocholate. They examined only one strain of each organism. 
A study by Aries et al. (3) reported that there was no bile salt hydrolase activity 
detected in 48 strains oflactobacilli tested. Conversely, Hill and Drasar (52) reported 
that they found only twelve strains of lactobacilli with no bile salt hydro lase activity. 
Gilliland and Speck (3 5) were the first to detect bile salt hydrolase activity in L. 
acidophilus. Several studies since then have reported the same results (13. 17). 
Dashkevicz and Feighner (17) found that 71 % of all the strains of L. acidophilus that they 
tested exhibited some bile salt hydrolase activity. 
Tannock et al. (122) studied the effect of Lactobacillus on the bile salt hydrolase 
activity in conventional, lactobacillus free, and reconstituted lactobacillus free mice. The 
lactobacillus free and reconstituted lactobacillus free mice differed in that the 
lactobacillus free mice did not contain lactobacilli, enterococci, and filamentous ileal 
microorganism while the reconstituted mice lacked only lactobacilli compared to the 
conventional mice. Lactobacilli were detected in the intestinal tracts of conventional 
mice and in the other two groups after inoculation with lactobacilli. The number of 
lactobacilli increased distally along the small intestine in the conventional mice and in the 
reconstituted lactobacillus free mice after inoculation with lactobacilli. The bile salt 
hydrolase activity in the conventional mice was 86% more than in reconstituted 
lactobacillus free mice and 98% higher than in the lactobacillus free mice. After 
inoculation with lactobacilli in the lactobacillus free mice groups, there were no 
significant differences in bile salt hydrolase activity in the small intestine between them 
and the conventional mice. Based on these results, lactobacilli play a major role in bile 
19 
salt deconjugation in the intestinal tract. The deconjugation of bile acids can lead to 
excretion of the acids and thus a reduction in the cholesterol stores in the body. 
Enterohepatic Circulation of Bile Acids 
The enterohepatic circulation of bile acids occurs between the liver and the small 
intestine. Bile acids are produced in the liver and then concentrated and excreted from 
the gall bladder into the small intestine. In the small intestine they act as emulsifiers and 
form micellular structures with lipids thus facilitating their absorption. The bile acids are 
reabsorbed with the lipids from the small intestine and are transported in the blood stream 
back to the liver (12). Only very small amounts of the conjugated bile acids are excreted 
with the feces. The bile acids that are recirculated are usually conjugated with glycine or 
taurine while the excreted bile acids are usually deconjugated (93). 
Absorption ofBile Acids 
Bile acids are absorbed by both active transport and passive diffusion depending 
on the location in the small intestine (20, 21, 23, 70, 76, 111). Active transport occurs 
primarily in the ileum while passive diffusion occurs in the duodenum and jejunum (22, 
23). Active transport requires both ionized molecules and bile acids that have negatively 
charged side chains (21). A study by Schiff et al. (111) reported that both conjugated and 
deconjugated bile acids can by absorbed by active diffusion in the ileum but the 
conjugated bile acids are absorbed more efficiently. 
The charge of the side chains of bile acids depends on the pKa. The pKa of cholic 
acid is around 6 (17, 21), fortaurocholic acid is 2 and for glycocholic acid is 5. As 
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mentioned previously, cholic acid is excreted more readily than its conjugated forms. 
Also, glycochoic acid predominates over taurocholic acid in the intestinal tract. The pH 
of the intestinal tract ranges from 4.5 to 6. In this pH range, both the taurocholic acid and 
glycholic acids would be ionized. Therefore they would be actively absorbed in the 
ileum. Conversely, cholic acid would be unionized in the small intestine and 
theoretically would be passively absorbed due to its uncharged side chains. In the ileum, 
the pH is higher and the cholic acid becomes charged thus facilitating absorption in this 
portion of the intestinal tract. However, Playhouse et al. (100) and Dietschy et al. (20) 
reported that cholic acid was not readily reabsorbed when they evaluated absorption 
using the everted gut sac technique. Conversely, another study (21) reported that cholic 
acid and conjugated bile acids were absorbed similarly in vivo. 
Role of Bile Acids in Establishing Gut Microflora 
Deconjugated bile acids have an inhibitory effect on microorganisms (32). 
However, cholic acid does not have the same effect. It has been reported that 
deoxycholic acid is the most inhibitory free bile acid and inhibits most gram negative 
organisms (115). Generally, Gram positive organisms are more sensitive to the inhibitory 
action of the bile acids than the Gram negative bacteria. However, there is variation 
among genera and species in the bile salt tolerance. 
For example, L. bulgaricus can not survive in the intestinal tract because of its 
sensitivity to bile salts (36). Conversely, L. acidophilus is a normal inhabitant of the 
intestinal tract (87). L. acidophilus is very tolerant of the bile salts in the intestinal tract, 
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but there is variation in the bile salt tolerance among strains (39, 40, 128). The bile salt 
tolerance may play a role in the hypocholeserolemic effects of the L. acidophilus. 
A study by Grill et al. ( 45) evaluated eight strains of bifidobacteria and their 
relationship with six different conjugated bile acids. The conjugated bile acids were 80% 
inhibitory toward all eight strains ofbifidobacteria. However, all eight strains produced 
deconjugated bile salts during growth which were identified by the researchers as the 
growth inhibiting factors. 
Other Health and Nutritional Benefits ofLactobacilli 
Antagonistic Action Towards Pathogens 
Several researchers have studied the antagonistic action of the lactobacilli toward 
various food-borne pathogens and spoilage organisms. Scientists have hypothesized that 
the inhibitory action is due to a number of factors including, production of hydrogen 
peroxide, acid, and/or bacteriocins. L. acidophilus appears to inhibit pathogens during 
refrigerated storage by producing hydrogen peroxide (4, 6, 34). BothL. casei and L. 
acidophilus inhibit pathogenic organisms both in vitro (6, 34, 104) and in vivo (9, 96, 99, 
109, 116, 117, 129, 130). Among the pathogens inhibited are Staphylococcus aureus (34, 
104, 116, 117, 129), Streptococcus spp. (116, 117), Salmonella spp (34, 129), 
Clostridium spp. (36, 116, 117, ), Vibrio spp (116, 117), Listeria (99, 109), and E. coli (6, 
34, 104, 130) 
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Growth Stimulation 
Infants who were solely formula fed had significantly less weight gain that those 
who were only formula fed and supplemented withL. acidophilus (107). They also 
found that breast fed infants gained significantly more weight than either of the two 
formula fed groups, but the supplement of L. acidophilus appeared to help infants gain 
weight at a rate more comparable to breast fed infants compared to those who were only 
fed formula. 
Benefits to Lactose Maldigestors 
Lactose maldigestion occurs because of a deficiency of lactase in the digestive 
system. After consumption of dairy products, persons with this condition may experience 
bloating, flatulence, diarrhea, and abdominal pain (68). 
Researchers have reported that various species of lactobacilli have the potential to 
improve lactose digestion in persons who are lactose maldigestors because they produce 
the enzyme B-galactosidase (3 8, 67). 
However, some have reported that consumption of L. acidophilus had no benefit 
to lactose maldigestors (89, 90, 110). Gilliland (42) reported that these studies did not 
consider the strains used or how the cells were propagated. The enzyme B-galactosidase 
is inducible in L. acidophilus. Therefore, in order for the L. acidophilus to have the 
greatest potential benefit the lactose maldigestors, the cells should be grown in a medium 
that has lactose as the sole carbohydrate source to ensure a high B-galactosidase activity. 
Additionally, Gilliland and Lara ( 41) reported that some strains of L. acidophilus lost 
their B-galactosidase activity in as little as 7 seven days of storage in nonfermented 
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acidophilus milk, but some strains remained active up to 21 days. Also, Noh and 
Gilliland {91) reported a wide variation in the B-galactosidase activity among strains of 
L. acidophilus. This data indicates that selection of the strain of L. acidophilus used to 
benefit lactose maldigestors is a critical step in ensuring that the organism alleviates the 
symptoms of lactose maldigestion. 
Production of Antitumor Compounds 
Researchers have reported that lactobacilli may be inhibitory to some types of 
cancers. A review article by Gilliland {39) reported that L. acidophilus could be 
inhibitory toward some organisms that produced carcinogenic compounds. He also 
reported that there is evidence that the lactobacilli administered in the diet reduced the 
proliferation of tumor cells in rats. 
Sellars {112) reported similar results. He indicated that L. acidophilus may be 
responsible for reducing the formation of carcinogenic compounds by fecal enzymes. He 
also mentions epidemiological evidence in countries where the populations consume 
large amounts of products containing L. acidophilus indicating lower rates of colon 
cancer than in other countries. 
Immunomodulating Effects 
Many researchers believe that lactic acid bacteria and bifidobacteria have a 
stimulating effect on the immune system. They have studied the mechanisms responsible 
for immune stimulation. 
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Yasui et al. (132) reported that mouse pups who were nursed by dams fed 
Bifidobacterium breve and immunized with rotavirus were more resistant to rotavirus-
induced diarrhea than pups nursed by dams who were only immunized. They discovered 
that there was more antirotavirus IgA in milk of the dams fed the bifidobacteria than in 
the dams who were only immunized. Similarly, Linc-Amster et al. (72) reported humans 
who consumed L. acidophilus and bifidobacteria were less susceptible to infection when 
challenged with S. "lyphymurium. Subjects who consumed the cultures had 4 times more 
IgA than the control subjects. Similar results were found by other researchers (63, 118) 
Schriffiin et al. (113) reported that humans who consumed fermented milk 
products supplemented with L. acidophilus or Bifidobacteriaum bifidum had no 
modification oflymphocyte subpopulations. However, in vitro studies indicated that 
phagocytosis of E. coli was enhanced concurrently with the intestinal colonization by the 
lactic acid bacteria. The increased phagocytosis persisted for six weeks after the products 
were ingested. 
Yasui and Ohwake ( 131) reported that bifidobacteria enhanced production of 
anitibodies by Peyer's patches, a gut associated lymphoid tissue. Additionally, 
researchers have reported that the live cells must be consumed to obtain the 
immunomodulating effects (78). 
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Products available that contain L. acidophilus and/or L. casei 
There are a number of products available to consumers that contain various 
species oflactobacilli. Among these products are fermented and nonfermented dairy 
products and liquid or dried forms of lactic cultures. 
Fermented acidophilus milk is readily available in Scandinavian and Eastern 
European Countries (112). It has an extremely sour taste and would not be readily 
accepted in the U.S. (69). 
Health food stores and pharmacies sell freeze-dried and liquid forms of products 
that contain various species of lactic acid bacteria including L. acidophilus and L. casei. 
However, no evidence is available to indicate the strains selected for these products were 
based on possession of specific activities that might provide potential health benefits and 
the viability is usually low (12, 36, 101). 
Nonfermented acidophilus milk is readily available in the U.S. Cells of L. 
acidophilus are added to the pasteurized, lowfat milk. The cells do not have any effect on 
the flavor of the milk. Gilliland (37, 43) reported that cells of L. acidophilus to be added 
to products as dietary adjuncts should have the following characteristics 1) the organism 
should normally be found in the intestinal tract, 2) the organisms should produce the 
desired effects in the intestinal tract and 3) the organisms should remain viable during 
storage of the product. 
Cells of L. acidophilus may be added to yogurt after fermentation in a similar way 
that they are added to nonfermented acidophilus milk. 
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L. casei is available in several countries in a drink called Yakult. This drink was 
developed in 1935 by Dr. Minoru Shirota (116). The drink is made by fermenting milk 
with L. casei var. Shirota. This organism is believed to be more acid tolerant than L. 
acidophilus. Studies have shown the drink is effective in treating constipation and 
diarrhea. However, a study indicated that continuous consumption ofYakult may be 
necessary to maintain high enough numbers of the organism in the intestinal tract (116). 
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ABSTRACT 
Lactobacillus acidophilus Ll and ATCC 43121 and Lactobacillus casei N19 and 
ES were evaluated for their ability to deconjuate bile acids and remove cholesterol from 
suspension in MRS broth during growth at a constant pH of6.0 and during growth 
without pH control. 
Samples grown without pH control dropped to pH levels of 4.2 to 4.5 during 20 h 
of incubation depending.on the culture. The plate counts indicated that populations in all 
cultures were near their maximum numbers after 16 hours of growth. The amount of 
cholesterol removed from the broth was similar for both strains of L. acidophilus grown 
with and without pH control. However, the strains of L. casei differed significantly in the 
amount of cholesterol removed from the broth between the two pH treatments. Both 
cultures of L. casei grown at pH 6.0 removed very little cholesterol from the broth while 
cells grown without pH control removed up to 60 ug of cholesterol/ml. All cultures 
deconjugated 60 to 90% of the bile salts, depending on the culture. Lactobacillus 
acidophilus L 1 was the only culture to have differences between the two pH treatments in 
the amount of bile salts deconjugated. These results indicate that most of the cholesterol 
removal from broth by L. acidophilus is due to assimilation, perhaps incorporation of 
cholesterol into the cellular membrane. Lactobacillus casei most likely removes 
cholesterol from broth due to destabilization of cholesterol micelles and coprecipitation 
of the cholesterol with the deconjugated bile salts at pH levels less than 6.0. 
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INTRODUCTION 
High serum cholesterol levels are associated with the development of coronary 
heart disease, the leading cause of death in the United States (66, 77, 78, 103). During 
growth, Lactobacillus acidophilus can remove cholesterol from laboratory media 
supplemented with cholesterol micelles and bile salts and may have the potential to 
reduce serum cholesterol levels in humans (8,18, 43). Lactobacillus casei also can 
remove cholesterol from a laboratory medium during growth (95). 
The mechanism that the organisms use to remove the cholesterol from the 
laboratory media is not completely clear. Klaver and Van der Meer (69) reported that the 
removal of cholesterol from laboratory media by L. acidophilus was due to the disruption 
of the cholesterol micelles caused by bile salt deconjugation and precipitation of the 
cholesterol with the free bile salts as the pH of the media dropped due to acid production 
during growth. 
Both L. acidophilus and L. casei deconjugate bile acids during growth by 
producing the enzyme bile salt hydrolase (17, 20, 70). The solubility of cholic acid, a 
deconjugated bile acid, decreases as the pH of the media decreases (22, 24, 25). The 
cholic acid is especially insoluble at pH levels less that 5 due to its pK of 5 to 6. As the 
pH drops due to acid production during bacterial growth, the cholic acid precipitates from 
the broth and may cause the cholesterol to precipitate also if the cholesterol micelles are 
disrupted. 
However, a study by Noh and Gilliland (96) revealed that L. acidophilus 
incorporates some of the cholesterol removed from laboratory media into the cellular 
membrane during growth. During growth at pH 6.0, a pH sufficiently high to keep the 
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deconjugated bile acids in solution, they still observed removal of cholesterol from a 
growth medium supplemented with cholesterol micelles and conjugated bile salts. 
Both deconjugation of bile acids and incorporation of cholesterol into the cellular 
membrane have the potential to lower serum cholesterol levels in humans. If the 
cholesterol is incorporated into the cellular membrane of the lactobacilli during growth in 
the small intestine, it is likely unavailable for absorption into the blood. The release of 
free bile acids through deconjugation of conjugated bile acids in the small intestine 
results in excretion of more bile acids in the feces (123). The primary means whereby 
cholesterol is removed from the body is by excretion in the form of deconjugated bile 
acids (137). Most conjugated bile acids are recirculated through enterohepatic 
circulation. The bile acids that are excreted must be replaced by new bile acids which are 
formed from cholesterol in the body. Thus, the more bile acids that are excreted, the 
more cholesterol is lost from the body's pool. Futhermore, free bile acids do not support 
absorption of cholesterol and other lipids from the small intestine as well as do 
conjugated ones (25, 105). 
The objective of this study was to determine if L. acidophilus and L. casei 
removed cholesterol from laboratory media in a similar manner by 1) determining if 
isolates of L. casei incorporate cholesterol into the cellular membrane, 2)determining if 
there was a difference in the amount of cholesterol removed from the laboratory media by 
both species when it was maintained at pH 6.0 during growth compared to growth 
without pH control, 3) determining the amount of sodium taurocholate deconjugated by 
the cultures during growth with and without pH control, and 4) determining if L. casei 
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preferentially to deconjugates sodium glycocholate or sodium taurocholate during growth 
with and without pH control. 
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MATERIALS AND METHODS 
Source and Maintenance of Cultures 
All cultures used in this study were from the stock culture collection of the Dairy 
Microbiology Laboratory at Oklahoma State University. Lactobacillus acidophilus 
ATCC 43121 was originally isolated from a pig. L. acidophilus LI and Lactobacillus 
casei strains A3, Al 7, ES, BIO, LIS, L19, MS, M12, N7, and N19 were all isolated from 
human intestinal sources by Buck and Gilliland (8). The cultures were maintained by 
subculturing 1 % inocula into MRS broth (Difeo Laboratories, Detroit, MI) and 
incubating them for 18 hours at 37°C. The cultures were stored at 7°C between transfers. 
Stock cultures were stored in MRS agar stabs. The cultures were subcultured at least 
three times immediately before they were used experimentally. 
Bacterial Growth Media 
MRS broth (Difeo Laboratories) was used for subculturing of the cultures. It was 
prepared according to manufacturer's instructions. MRS agar was prepared by adding 
1.5% agar to MRS broth. 
MRS-TiilO broth was prepared by supplementing MRS broth with 0.2% sodium 
thioglycolate (Sodium Salt, Sigma Chemical Co., St. Louis, MO). This broth was further 
supplemented with 10% cholesterol micelles (to yield 90-100 ug cholesterol per ml) and 
6 mM sodium taurocholate (Sigma chemical Co.) or with 2.8 mM sodium glycocholate 
(Sigma Chemical co.), and 1.2 mM sodium taurocholate when needed. 
All media was sterilized by autoclaving for 15 minutes at 121°C. All media 
containing sodium thioglycolate was prepared the day they were used experimentally. 
44 
Initial Screening of Cultures for Cholesterol Removal and Bile Salt Deconjugation 
The cultures of L. casei were isolated from human intestinal sources in a previous 
study (8). They represented some of the lactobacilli other than L. acidophilus described 
in that study. Determination of their identity characteristics, relative abilities to remove 
cholesterol from the medium and to deconjugate sodium taurocholate were done as 
described earlier (8). The growth medium used was the same as described above except 
0.3% oxgall was used in place of either sodium glycocholate or sodium taurocholate. 
The medium contained 90-100 ug cholesterol per ml. 
Incorporation of Cholesterol into the Cellular Membrane of L. casei 
Strains ES and Nl 9 of L. casei were examined for their ability to incorporate 
cholesterol into their cellular membrane. Isolation and evaluation of cholesterol content 
of the membrane was done as described by Noh and Gilliland (96). 
Growth of Cultures with and without pH Control 
On the day of the experiment, 800 ml ofMRS-THIO broth which contained 6 
mM sodium taurocholate was prepared. After cooling, the broth was supplemented with 
80 ml (10%) cholesterol-phosphatidylcholine micelles prepared according to Razin et al. 
(109). The micelles were prepared using egg yolk lecithin (Type 111-e, Sigma Chemical 
Co.). The concentration of cholesterol in the broth was 90-100 ug/ml. The media was 
mixed thoroughly and 10 ml of the broth was removed and placed into a sterile tube and 
held at S°C (Uninoculated control or time 0). 
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The broth was then inoculated with 8 ml of a freshly prepared MRS broth culture 
ofthe appropriate strain to be evaluated. (L. acidophilusLI and ATCC 43121 andL. 
casei ES and NI 9 were all examined.) The broth was then aseptically transferred in equal 
portions into each of two sterile fermentor jars ( each approximately 11 capacity). One of 
the fermentor jars was equipped with a combination pH electrode and ports for the 
addition of neutralizer, continuous sparging with nitrogen gas, and sample removal. The 
automatic pH controller was adjusted to maintain the pH at 6.0 during growth by adding a 
neutralizer containing S% sodium carbonate in S% ammonium hydroxide ( 46). Nitrogen 
gas was purged through the broth at a rate of IO ml/minute to help. maintain a low 
oxidation-reduction potential. The culture in the other fermentor jar was incubated 
statically, without pH control at 37°C. The temperature for both was maintained at 37°C 
in a water bath. 
Samples were aseptically removed and placed into sterile tubes for evaluation 16, 
18, 20, and 22 hours after growth. Samples were stored in a mixture of ice and water 
until they were examined (not more than 30 min). They were examined for pH, plate 
counts on MRS agar, bile salt deconjugation and removal of cholesterol from the broth. 
Deconjugation of Sodium Glycocholate and Sodium Taurocholate 
Experiments were done as described in the previous section. Lactobacillus casei 
ES and Nl9 were compared. These experiments differed from the experiments described 
in the previous section in that there was no cholesterol added to the broth and 2.8 x 10-3 
mM/ml of sodium glycocholate and 1.2 x I 0-3 mM/ml sodium taurocholate were added to 
the broth instead of just sodium taurocholate. This concentration was chosen because it 
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resembles the ratio in the human body (10, 117). All other parameters were similar to the 
previously described experiment. 
Samples were aseptically removed and placed into sterile tubes for evaluation 16, 
18, 20, and 22 hours after growth. Samples were stored in a mixture of ice and water 
until they were examined (not more than 30 min). They were tested for deconjugation ·or 
bile acids. 
Measurement of Cholesterol Removal 
The time O sample removed initially from the fermentor served as an uninoculated 
control for the measurement of cholesterol assimilation. The amount of cholesterol 
remaining in the MRS broth was determined at 16, 18, 20, and 22 hours after growth for 
cultures grown with and without pH control. The cells were removed from broth samples 
by centrifugation at 12,000 x g at 4°C for 10 minutes. The supernatant was recovered and 
the amount of cholesterol remaining in it was determined. 
The o-phthalaldehyde method described by Rudel and Morris (115) was used to 
determine the amount of cholesterol in the sample. The amount of cholesterol removed 
from the broth was determined by subtracting the amount in each broth sample (ug/ml) 
from the amount originally present in the uninoculated control. 
Plate Counts ofLactobacilli in Samples 
The total numbers of lactobacilli were determined using the pour plate method as 
described in the Compendium of Methods for the Microbiological Examination of Foods 
(136) on MRS agar. The samples were serial diluted in 99 ml 0.1% peptone (Sigma) 
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dilution blanks containing 0.01% silicone antifoamer (Sigma chemical Co., St. Louis, 
MO). Plates were incubated in a 37°C incubator for 48 hours. Colonies were counted 
with the aid a Quebec Colony Counter.and the cfu/ml was determined. The cfu/ml was 
converted to log10 cfu/ml for statistical examination. 
Bile Salt Deconjugation 
The amounts ofbile salt (sodium taurocholate or sodium glycocholate) 
deconjugated by the lactobacilli were determined using HPLC analysis as described by 
Corzo (17). Methanol-acetate buffer pH 5.0 was used as the mobile phase. Two ml of 
sample were suspended in 8 ml of0.9% NaCl in 0.1 MNaOH and 6 ml of mobile phase. 
The bile salts were recovered by passage of the solution through a Sep-Pac cartridge 
(Waters Assoc.) and the bile salts were eluted from the cartridge with 3 ml of mobile 
phase. Dexamethasone (0.2 mg/ml) was added to the eluate as an internal standard. 
Statistical Analyses 
The experimental design of this experiment was repeated measures over time in a 
split plot with the main units in a completely randomized design. The main unit 
treatments were cultures, the sub-unit treatments were pH treatments, and the repeated 
measures were sampling times. PROC MIXED command of the SAS system was used to 
separate means. 
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RESULTS 
Initial Screening of Cultures for Cholesterol Removal and Bile Salt Deconjugation 
The identity of the cultures of L. casei compared in this study were confirmed 
(Table 49 in Appendix C). The identity characteristics of all 10 closely matched those of 
L. casei as presented in Bergey 's Manual of Determinative Bacteriology (7). There were 
significant differences (P<.05) among the ten strains of L. casei with regard to the 
amounts of cholesterol removed from suspension in the growth medium during 24 h 
incubation (Table 1). Significant differences (P<.05) in deconjugation of sodium 
taurocholate also were observed among cultures (Table 2). Lactobacil/us caseiElO, E5, 
L15, and M5 which deconjugated greater amounts of bile salt than the other six strains 
also were among the most active in removing cholesterol from suspension in the growth 
medium. Because of the apparent relationship between deconjugation of sodium 
taurocholate and removal of cholesterol from the growth medium, two strains were 
chosen for further study. Strains E5 and Nl9 were among the most active in removing 
cholesterol from the growth medium. However, they exhibited the greatest difference in 
deconjugation of sodium taurocholate. Two strains ofL. acidophilus, Ll and 43121, 
shown to be very active in removal of cholesterol from growth media in previous studies 
(8, 43) were selected for comparison withL. casei ES and Nl9. 
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Removal of Cholesterol from the Broth 
Statistical analysis indicated that there were significant (P<.05) culture*time, 
culture*treatment, and culture*time*treatment interactions. Because of this, we 
examined the results at each sampling time at each level of the other factors in the 
interaction. The pattern indicates that each culture behaves differently with regard to 
removal of cholesterol from the broth at each sampling time and pH treatment. 
Since the maximum amounts of cholesterol had been removed after 20 hours of 
growth for all cultures, the results are summarized for that time in Table 3. Data for all 
sampling times can be found in Appendix A. Lactobacillus casei E5 and Nl 9 removed 
56.6 and 36.3 ug of cholesterol/ml, respectively after 20 hours of growth without pH 
control. These amounts were not significantly different (P>.05). However, both differed 
significantly (P<.05) from the amounts initially present in the broth. Both cultures of L. 
casei grown at pH 6.0 removed very little cholesterol from the broth. Strain ES removed 
8.0 ug/ml while N19 removed 10.4 ug/ml. Neither of these amounts was significantly 
(P>.05) different from the amount present initially (Appendix A Table 4). Thus, little or 
none was removed during growth at pH 6.0. 
Both strains of L. acidophilus removed significant (P<.05) amounts of cholesterol 
from the broth when grown at pH 6.0 and without pH control. Lactobacillus acidophilus 
Ll grown at pH 6.0 removed 46.9 ug/ml while without pH control 44.7 ug/ml were 
removed. The amount removed from the broth by strain 43121 grown at pH 6.0 was not 
significantly different (P>.05) from the amounts removed by strain Ll. However, strain 
43121 grown without pH control removed 60.6 ug of cholesterol/ml, significantly more 
(P<.05) than when grown at pH 6.0. 
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Deconjugation of Sodium Taurocholate 
There was a significant (P<.05) interaction between cultures and time. This 
indicates that the cultures did not deconjugate comparable amount of sodium taurocholate 
at the various sampling times. However, the cultures behaved similarly between the two 
pH treatments. We analyzed the results from each sampling time at each level of the 
other factors in the interaction. The data for 20 his summarized in Table 3. Data for the 
other sampling times are in Appendix A Table 5. 
Lactobacillus acidophilus 43121 deconjugated the most sodium taurocholate after 
20 hours of growth at pH 6.0 and without pH control than did any of the other cultures. 
There was a total of 4.8 mM of the bile salt deconjugated for cells grown at both pH 
treatments. Lactobacillus acidophilus LI grown at pH 6.0 deconjugated the least amount 
of cholesterol removing only 2.1 mM. When grown without pH control, it removed 4.1 
mM which was significantly (P<.05) more than the amount removed by cells grown at 
pH 6.0, but not significantly different (P>.05) from the amount deconjugated by either 
strain of L. casei. 
Lactobacillus casei ES and Nl 9 deconjugated similar amounts of sodium 
taurocholate under both growth conditions. Strain ES deconjugated 4.2 mM and 4.0 mM 
grown at pH 6.0 and without pH control, respectively, while strain N19 deconjugated 3.6 
mM when grown at pH 6.0 and 3.4 when grown without pH control. 
Plate Counts of Lactobacilli 
There were no significant interactions (P>.OS) among cultures, time or treatments 
for the plate count data. Generally, cells grown at pH 6.0 reached higher numbers than 
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those grown without pH control. There were no significant (P>.OS) differences between 
the two growth conditions for L. casei ES and N19. There also were no significant 
(P>.OS) differences in the numbers reached by the two stains of L. casei. 
There were significant (P<.OS) differences for both strains of L. acidophilus 
grown with and without pH control. Strain 43121 grown at pH 6.0 reached a population 
of 9.3S log1o cfu/ml after 20 hours of growth while cells grown without pH control were 
about one log cycle lower, 8.36 logio cfu/ml. Strain Ll showed a similar pattern. Cells 
grown at pH 6.0 reached a population of 8.84 logio cfu/ml while cells grown without pH 
control were significantly less (P<.OS) at a population of 7.99 logio cfu/ml. 
pH of the Broth 
The pH of all samples began at 6.5. Cells of all cultures grown with pH control 
were allowed to produce enough acid to reduce the pH to 6.0 which was then maintained 
throughout the remainder of the sampling period. Lactobacillus casei ES and N19 and L. 
acidophilus Ll 43121 produced enough acid to lower the pH to 4.2, 4.2, 4.3 and, 4.6 
respectively after 20 hours of growth. 
Deconjugation of Sodium Glycocholate and Sodium Taurocholate 
L. casei ES and N19 varied in the amount of sodium taurocholate and sodium 
glycocholate deconjugated. Strain ES appeared to have more deconjugating activity than 
strain Nl9. Generally, both strains preferred sodium glycocholate over sodium 
taurocholate. 
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Strain ES deconjugated most of the 2.8 x 10·3 mM/ml of sodium glycocholate 
before it began to deconjugate the sodium taurocholate (Fig IA and IB, Appendix A 
Table 8). The culture grown with pH control appeared to deconjugate the bile acids at a 
slightly slower rate than the cells grown without pH control. However, by 22 hours of 
incubation, the cultures grown under both conditions had removed 2.8 mM x 10"3/ml 
(100%) of the sodium glycocholate from the broth. It did not deconjugate all of the 
sodium taurocholate under either conditions (S7% with pH control and 67% without pH 
control). 
L. casei NI9 deconjugated significantly (P<.OS)less sodium taurocholate than 
strain ES at 16, 18, and 20 hours of growth at pH 6.0 and at all sampling times when 
grown without pH control (Fig lB and 1 C, Appendix A Table 8). Strain Nl 9 also 
deconjugated significantly less (P<.OS) sodium glycocholate after 16 and 20 hours of 
growth at pH 6.0 and at all sampling times for cells grown without pH control. 
Examination of Cellular Membrane of L. casei for Cholesterol 
Examination of the cellular membranes isolated from L. casei grown in the broth 
medium containing cholesterol and sodium taurocholate at pH 6.0 and without pH control 
revealed no cholesterol. Thus there is no evidence for incorporation of cholesterol in the 
cellular membrane of L. casei under the conditions of growth utilized in this study. 
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DISCUSSION 
Several reports indicate that some lactobacilli can remove cholesterol from 
suspension in laboratory media during growth (8, 18, 43). Some scientists believe that 
the cholesterol is removed by lactobacilli because of bile salt deconjugation. They 
theorize that when bile salts are deconjugated and the pH of the media drops due to 
natural acid production by the culture, the cholesterol micelles destabilize and cholesterol 
precipitates with the free bile acids (69). Bile acids are less soluble and are more likely to 
precipitate at pH levels less than 6.0 (22, 24, 25). 
However, a study by Noh and Gilliland (96) revealed that cholesterol was 
removed from laboratory media by L. acidophilus ATCC 43121 and Ll when the pH was 
maintained at 6.0. At this pH, there should have been very little precipitation of bile 
acids. They also found that some of the cholesterol was incorporated into the cellular 
membrane of the organism. In the present study, isolation of the cellular membrane of L. 
casei and examination of cholesterol revealed that L. casei under the conditions tested did 
not incorporate cholesterol into the cellular membrane in measurable amounts. 
In our study, the amount of cholesterol removed from the broth was variable 
depending on the culture and the pH of growth. L. acidophilus L 1 was the only culture 
among the ones evaluated that did not differ in the amount of cholesterol removed when 
grown with or without pH control. Although there were significant differences in the 
amounts of cholesterol removed during growth with and without pH control, L. 
acidophilus 43121 was similar to L. acidophilus Ll in that it removed large amounts of 
cholesterol even when the broth was maintained at pH 6.0. Since free sodium cholate 
stays in solution at pH 6.0 (22, 24, 25), these results further suggest that the cholesterol 
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removed from the broth by L. acidophilus was not due just to bile salt deconjugation and 
coprecipitation of cholesterol with free sodium cholate. Thus it is likely that much of the 
cholesterol removed from suspension from the broth was not entirely due to 
destabilization of the cholesterol micelles. 
The amount of bile salts deconjugated by L. acidophilus Ll was significantly 
different between the two growth conditions while the amount deconjugated by L. 
acidophilus 43121 was not The difference in the amounts of bile salts deconjugated 
during growth with and without pH control and the lack of difference in the amount of 
cholesterol removed from the broth between the two treatments, and visa versa, further 
suggests that the cholesterol removal was not entirely related to bile salt deconjugation 
for L. acidophilus L 1. 
The two strains of L. casei · exhibited significant differences in the amount of 
cholesterol removed from the broth during growth with and without pH control. There 
was very little cholesterol removed from the broth maintained at pH 6.0 while the 
amounts removed from suspension were comparable to the amount removed by L. 
acidophilus when the cells were grown with no pH control. These results suggest that 
most of the cholesterol removed from the broth by L. casei was due to coprecipitation of 
the cholesterol with the deconjugated bile salts. There was very little difference in the 
amount of sodium taurocholate deconjugated for either strain for the two pH treatments. 
However, the bile salts deconjugated by the cultures grown at pH 6.0 would have 
remained in solution. Therefore the cholesterol stayed in suspension. 
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Further experiments indicated that both strains of L. casei deconjugated sodium 
glycocholate better than sodium taurocholate. Sodium glycocholate predominates in the 
intestinal tract of adults because there is very little taurine in the diet (24). Strains that 
prefer to deconjugate sodium glycocholate thus may have more potential in lowering 
serum cholesterol levels if deconjugation of bile salts is important in controlling serum 
cholesterol. 
Either mechanism, bile salt deconjugation or cholesterol assimilation, has 
potential importance in exerting control of serum cholesterol levels in humans. 
Cholesterol incorporated into or adhered to the bacterial cells likely would be less 
available for absorption from the intestine into the blood. Deconjugated bile salts are less 
well absorbed in the enterohepatic circulation thus are more likely to be excreted in the 
feces. Excreted bile salts are replaced by synthesis of new ones in the body from 
cholesterol, thus providing the potential ofreducing the body's pool of cholesterol. 
Furthermore free bile salts do not support absorption of lipids, including cholesterol from 
the intestines as well as do conjugated bile salts (25, 105). Results from this study 
suggest that strains of L. acidophilus should be selected not only on the basis of bile salt 
deconjugation, but also should be examined for cholesterol assimilation. When selecting 
strains of L. casei for use as dietary adjuncts, it is important to select strains with the 
highest bile salt deconjugating activity to maximize the potential for reduction of serum 
cholesterol levels. Based on our observation it does not appear that cholesterol 
assimilation of L. casei could be a major factor in controlling serum cholesterol. 
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Table 1. Comparison of amounts of cholesterol removed from suspension in growth 
medium by isolates of Lactobacillus casei from human volunteers. 
Culture Cholesterol Removed · 
ES 73.3a 
EIO 61.4ab 
MS S6.6abc 
LIS 48_8abcd 
Nl9 4S.4abcd 
Al? 34.Sbcd 
N7 32.2bcd 
Ll9 30.9bcd 
A3 28.6cd 
Ml2 16.9d 
1ug/ml cholesterol removed by the culture during a 24 hour incubation at 37°C. 
2Values are the means of three replications. Me~ns with no common superscript letter 
differ significantly (P<.OS). 
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Table 2. Comparison of deconjugation of sodium taurocholate by isolates of 
Lactobacillus casei from human volunteers. 
Culture Bile Salt Deconjugated· 
ElO 1.6a 
ES I.Sa 
L15 1.4a 
MS 0.8b 
N7 0.3c 
A17 0.2c 
.. 
M12 0.2c 
A3 0.2c 
N19 O.lc 
L19 O.lc 
1uMol/ml bile salt deconjugated after incubation for 15 hours at 37°C 
2Values are the meilns of three replications. Means with no common superscript letters 
differ significantly (P<.05) 
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Table 3. Cholesterol removal, bile salt deconjugation, pH and plate counts on MRS agar of Lactobacillus casei and 
Lactobacillus acidophilus grown for 20 hours with and without pH control at 37°C. 
Plate Growth 
Culture Conditions 
Cholesterol 
Removed1 Deconjugation2 ···-- . __ __ . Counts3 ___1>.H 
ES 
N19 
43121 
LI 
pH6,0 
Static 
pH6.0 
Static 
pH6.0 
Static 
pH6.0 
Static 
8.0a 
56.6bc 
10.4a 
36.3b 
41.6b 
60.6c 
46.9bc 
44.7bc 
4.2b 9.77b 6.0 
· 4.0b 8.56ab 4.2 
3.6b 9.21b 6.0 
3.4b 8.62b 4.2 
4.8c 9.35b 6.0 
4.8c 8.36a 4.3 
2.e 8.84b 6.0 
4.lb 7.99a 4.6 
abcy alues represent the means of three replications. Means with no common superscript letters within each column differ 
significantly (P<.05). Due to the nesting design of this experiment, standard errors have wider ranges when comparing two 
different cultures compared to standard errors within a single culture. 
1Cholesterol reported as ug of cholesterol removed/ml of broth. 
2Deconjugation of sodium taurocholate; initial concentration of 6 mM; reported as mM deonjugated. 
3Reported as Log10 cfu/ml. 
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pH 6.0 No pH Cor:trol 
3 3 
l A' l I B L -~2 2 • ~ 8 _._Glycocholate ~ · I / 1--Glycocholate 
-<>-Taurocholate . 8 -o-Taurocholate 
E5 b1 ·b1 
.-l .-l 
0 . 0 
0 16 18 20 22 O 16 18 20 22 
0 Sample Titre (rours) Sample Titre (rours) 
3 3 ~ 
L • l1 _._Glycocholate l j 1-+-Glycocholate • ~1 I 2 -Taurocholate I 2 - .. -Taurocholate 
Nl9 S: C S:~~ 
0 16 18 20 22 0 16 18 20 22 
Sample Titre (rours) Sample Titre (rours) 
COMPREHENSIVE BIBLIOGRAPHY 
1. Ahmed, A.A., RD. McCarthy, and G.A. Porter. 1979. Effect of milk constituents 
on hepatic cholesterolgenesis. Arteriosclerosis. 32;347. 
2. Apella, M.C., S.N. Gonzalez, N.C. Romero, M.E. Nader de Macias, and G. Oliver. 
1992. In vitro studies on the inhibition of the growth of Shigella sonnei by 
Lactobacillus casei and Lactobacillus acidophilus . . J. Appl. Bacteriol. 73 :480. 
3. Aries, V., J.S. Crawther, B.S. Drasar, and M.J. Hill. 1969. Degradation ofbile salts 
by human intestinal bacteria. Gut. 10:575. 
4. Attaie, R., P.J. Whalen; K.M. Shahani and M.A. Amer. 1987. Inhibition of growth 
of StapJ,ylococcus aureus during production of acidophilus yogurt. J. Food 
Prot. 50:224. 
5. Bazzarre, T.L., S.L. Wu, and J.A. Yuhas. 1983. Total and HDL-cholesterol 
concentrations following yogurt and calcium supplementation. Nutr. Rep. 28: 
1225. 
6. Brashears, M:M., S.S. Reilly and S.E. Gilliland. 1996. Inhibitory actions of 
Lactobacillus lactis on Escherichia coli 0157:H7 during storage at 7°C in broth 
and on raw chicken meat. 1996 Animal Science Research Report. p. 51. 
7. Buchanan, RE., and N.E. Gibbons. 1974. Bergey 's Manual of Determinative 
Bacteriology (8th ed). The Williams and Wilkins Co., Baltimore, MD. 
8. Buck, L.M., and S.E. Gilliland. · 1994. Comparison of freshly isolated strains of 
Lactobacillus acidophilus of human mtestinal origin for ability to assimilate 
cholesterol during growth. J. Dairy Sci. 77:2925. 
9. Buck, L.M. 1992. M.S. Thesis Oklahoma State University. 
10. Burnett, W. 1965. Cited by Haslewood, G.A.D. 1967. Bile Salts. Methuen and 
Co. Ltd. pp. 68-69. 
11. Carey, M.C. 1982. The enterohepatic circulation. In Arias, J.M., H. Popper, D. 
Schacter, and D.A. Shafritx (eds), The Liver pp. 429-465. Raven Press, 
New York. 
12. Chikai, T., H. Nakao, an D. K. Uchida. 1987. Deconjugation of bile acids by 
human intestinal bacteria implanted in germ free rats. Lipids. 22:669. 
61 
13. Clark, M.L., and J.T. Harries. 1975. Absorption ofLipids in Intestinal Absorption 
in Man (McColl, I. and G.E. Sladen, eds). pp.187-221, Academic Press, 
London. 
14. Clements, M.L., M.M. Levine, RE. Black, RM. Robins-Browne, L.A. Cisneros, 
G.L. Drusano, C.L. Lanata and A.J. Saab. 1981. Lactobacillus prophylaxis for 
diarrhea due to enterotoxigenic Escherichia coli. Antimicrob. Agents and 
Chemother. 20:104. 
15. Cole, C.B. and R Fuller. 1984. Bile acid deconjugation and attachment of chicken 
gut bacteria: Their possible role in growth depression. Brit. Poultry Sci. 25:227. 
16. Conner, W.E., D.B. Stone, and RE. Hodges. 1964. The interrelated effects of 
dietary cholesterol and fat upon human serum lipid levels. J. Clin. Invest. 
43:1691. 
17. Corzo, G.A. · 1997. Bile salt deconjugation by three strains of Lactobacillus 
acidophilus and characterization of their bile salt hydrolase. Ph.D. dissertation, 
Oklahoma State University.• 
18. Danielson, A.D., E.R Peo, K.M. Shahani, A.I. Lewis, P.J. Whalen, and M.A. Amer. 
1989. Anticholeseremic property of Lactobacillus acidophilus yogurt fed to 
mature boars. J. Anim. Sci. 67:966. 
19. Danielson, H., and B. Gustafson. 1959. On serum-cholesterol levels and neutral 
fecal sterols in germ-free rats. Bile acids and steroids 59. Arch. Biochem. 
Biophys. 83 :482. 
20. Dashkevicz, M.P. and S.D. Feighner. 1989. Development ofa differential medium 
for bile salt hydrolase-active Lactobacillus spp. Appl. Environ. Microbial. 
55:11. 
21. DeRodas, S.E. Gilliland, and C.V. Maxwell. 1996. Hypocholesterolemic action of 
Lactobacillus acidophilus ATCC 43121 and calcium in swine with 
hypercholesterolemia induced by diet. J. Dairy Sci. 79:2121. 
22. Dickenson, A.B., 13.E. Gustafasson, and A Normal 1972. Determination of bile 
acid conversion potencies of intestinal bacteria by screening in vitro and 
subsequent establishment in germ free rats. Acta. Path. Microbiol. Scan. 
B79:691. 
23. Dietschy, J.M., H.S. Salomon, and M.D. Siperstein. 1966. Bile acid metabolism. I. 
Studies on the mechanisms ofintestinal transport. J. Clin. Inves. 45: 832. 
62 
24. Dietschy, J.M. 1968. Mechanisms for the intestinal absorption of bile acids. J. 
Lipid Res. 9:297. 
25. Dietschy, J.M., and D.J. Wilson. 1970. Regulation of cholesterol metabolism. New 
Engl. J. Med. 282:1179. 
26. Dowling, R.H. 1972. Progress In Gastroenterology: The enterohepatic circulation. 
Gastroenterology. 62: 122. 
27. Dujovne, C.A., P. Krehbiel, S. Decoursey, B. Jackson, S.B. Chernoff, A. Pitterman, 
and M. Garty. 1984. Producol with colestipol in the treatment of 
hypercholesterolemia. Ann. Intern. Med. 100:477. 
28. Dulery, C., and D. Reisser. 1982. Intestinal absorption of biliary and exogenous 
cholesterol in the rat. Biochem. Biophys. Acts. 710:164. 
29. Dull, B.J., RD. McCarthy, and A. Kilara. 1983. The modulating effect of an 
inhibitor of cholesterolgenesis present in bovine milk upon the synthesis of 
cholesterol, dolichol and ubiquinone. Arteriosclerosis. 49:231. 
30. Efrati, H., S. Rottem, and S. Razin. 1981. Lipid and protein membrane components 
associated with cholesterol uptake by mycoplasmas. Biochim. Biophys. Acta 
641:386. 
31. Eyssen, H. 1973. Role of gut microflora in metbolism of lipids and sterols. Proc. 
Nutr. Sci. 32:59. 
32. Fernandes, C.F., K.M. Shahani, and M.A. Amer. 1987. Therapeutic role of dietary 
lactobacilli and lactobacillic fermented dairy products. FEMS Microbiol. Rev. 
46:343. 
33. Ferriera, C. 1977. Effect of culture organisms on some nutritional properties of 
yogurt. M.S. Thesis. University ofWisconsin, Madison. 
34. Field, F.J., N.T.P. Kim, and S.N. Mathur. 1990. Regulation of cholesterol 
metabolism in the intestine. Gastroenterology. 99:539. 
35. Floch, M.M., H.J. Binder, B. Filburn, and W. Tershengoren. 1972. The effect of 
bile acids on intestinal microflora. J. Clin. Nutr. 25:1418. 
36. Gallo-Torres, M.E., O.N. Miller, and J.G. Hamilton. 1969. A comparison of the 
effect of bile salts on the absorption of cholesterol from the intestine of the rat. 
Biochimica et Biophysica Acta. 176:605. 
63 
37. Gilliland, S.E. and M.L. Speck. 1974. Antagonistic action of La.ctobacillus 
acidophilus toward intestinal and foodbome pathogens I associative cultures. J. 
Food Prot. 40: 820. 
38. Gilliland, S.E. and M.L. Speck. 1977. Deconjugation of bile acids by intestinal 
lactobacilli. Appl. Environ. Microbiol. 33:15. 
39. Gilliland, S.E. and M.L. Speck. 1977. Instability of Lactobacillus acidophilus in 
yogurt. J. Dairy Sci. 60: 1394. 
40. Gilliland, S.E. 1979. Beneficial interrelationships between certain microorganisms 
and humans: candidate microorganisms for use as dietary adjuncts. J. Food Prot. 
42:164. 
41. Gilliland, S.E. and H.S. Kim. 1984. Effect of viable starter culture bacteria in 
yogurt on lactose utilization in humans. J. Dairy Sci. 67: 1. 
42. Gilliland, S.E., T.E. Staley, and L.J. Bush. 1984. Importance of bile tolerance of 
Lactobacillus acidophilus used as a dietary adjunct. J. Dairy Sci. 67:3045. 
43. Gilliland, S.E., C.R. Nelson, and C. Maxwell. 1985. Assimilation of cholesterol by 
La.ctobacillus acidophilus. Appl. Environ. Microbiol. 49:377. 
44. Gilliland, S.E. and RC.Lara. 1988. Influence of storage at freezing and subsequent 
refrigeration temperatures on B-galactosidase activity of Lactobacillus 
acidophilus. Appl. Environ. Microbiol. 54:898. 
45. Gilliland, S.E. 1990. Health and nutritional benefits from lactic acid bacteria. 
FEMS Microbiol. Rev. 87: 175. 
46. Gilliland, S.E. and C.N. Rich. 1990. Stability during frozen and subsequent 
refrigerated storage of La.ctobacillus acidophilus grown at different pH. J. 
Dairy Sci. 73:905. 
47. Gilliland, S.E., and D.K. Walker. 1990. Factors to consider when selecting a 
culture of Lactobacillus acidophilus as a dietary adjunt to produce a 
hypocholesterolemic effect in humans. J. Dairy Sci. 73:905. 
48. Gopal-Srivastava, R. and P.B. Hylemon. 1988. Purification and characterization of 
bile salt hydrolase from Clostridium pe,fringens. J. Lip. Res. 29: 1079. 
49. Grill, J.P., C. Manginot-Durr, F. Schneider, and J. Ballongue. 1995. Bifidobacteria 
and probiotic effects: action of Bifidobacterium species on conjugated bile salts. 
Curr. Microbio. 31 :23. 
64 
50. Grundy, S.M, and D.W. Bilheimer. 1984. Low density lipoprotein receptors and 
enterohepatic circulation. In Enterohepatic Circulation of Bile acids and Sterol 
Metabolism. Paumgartner, G., A. Steihl, and W. Gerok (eds). MIE Press Ltd., 
Boston, MA. 
51. Grunewald, K.K. 1982. Serum cholesterol levels in rats fed skim milk fermented by 
Lactobacillus acidophilus. J. Food Sci. 47:2078. 
52. Haggerty, R.J., L.O. Luedecke, C.W. Nagel, and L.K. Massey. 1984. Effect of 
selected yogurt cultures on the concentration of orotic acid, uric acid and a 
hydroxymethylglutaric-like compound in milk after fermentation. J. Food Sci. 
49:1194. 
53. Harden, K.K., and J.L. Robinson. 1984. Hypocholesteremia induced by orotic acid: 
dietary effects and species specificity. J. Nutr. 114:411. 
54. Harrison, V.C. and G. Peat. 1975. Serum cholesterol and bowel flora in the 
newborn. Am. J. Clin. Nutr. 28:1351. 
55. Hepner, G., R. Fried, S.S. Jeor, L. Fusetti, and R..Morin. 1979. 
Hypocholesterolemic effect of yogurt and milk. Am. J. Clin. Nutr. 32: 19. 
56. Hill, M.J. and B.S: Drasar. 1968. Degradation of bile salts by human intestinal 
bacteria. Gut. 9:22. 
57. Hoffinan, A.F. 1977. The enterohepatic circulation of bile acids in man. Clin. 
Gastroenterol. 6:3. 
58. Holt, R. 1972. The roles of bile acids during the process of normal fat and 
cholesterol absorption. Arch. Intern. Med. 130:574. 
59. Howard, A.N., and J. Marks. 1982. The lack of evidence for a hypocholesterolemic 
factor in milk. Arteriosclerosis. 45:243. · 
60. Hunt, S.M., and J.L. Groff. 1990. Advanced Nutrition and Human Metabolism. 
pp.97-128. West Publishing Co. St. Paul, MN. 
61. Hylemon, P.B and T.L. Glass. 1983. Biotransformation of bile acids and 
cholesterol by the intestinal microflora. pp. 189-213. In D.J. Hentages (Ed.), 
Human Intestinal Microflora in Health and Disease. Academic Press, Inc., N.Y., · 
New York. 
65 
62. Imaizumi, K., K. Hirata, M. Zommara, M. Sugano, and Y. Suzuko. 1992. Effects 
of cultured milk products by Lactobacillus and Bi.fidobacterium species on the 
secretion of bile acids in hepatocytes and in rats. J. Nutr. Sci. Vitaminol. 38:343. 
63. Jaspers, D.A., L.K. Massey, and L.O. Luedecke. 1984. Effect of consuming 
yogurts prepared with three culture strains on human serum lipoproteins. J. 
Food Sci. 49: 1178. 
64. Jones, R.J. (ed). 1970. Arteriosclerosis - Proceedings of the Second Annual 
International Symposium. Springer-Verlag. N.Y., New York. 
65. Jonsson, G., A.C. Midtvedt, A Norman, and t. Bidtvedt. 1995. Intestinal microbial 
bile acid transformation in healthy infants. J. Pediart. Gastroenterol. Nutr. 
20:394. 
66. Kannel, W.B., W.P. Castelli, and T. Gordon .. 1979. Cholesterol in the prediction of 
arteriosclerotic disease. New perspectives based on the Framingham study. 
Ann. Intern. Med. 90:85. · 
67. Kitazawa, H., K. Matsumura, T. Ito.h, T. Yamaguchi. 1992. Interferon induction in 
murine peritoneal macrophage by stimulation with Lactobacillus acidophilus. 
Microbiol Immunol. 36:311. · 
68. Kiyosawa, H., C, Sugawara, N. Sugawara, and H .. Miyake. 1984. Effect of skim 
milk and yogurt on serum lipids and development of sudanophilic lesions I 
cholesterol-fed rabbits. Am. J. Clin. Nutr. 40:479. · · 
69. Klaver, F.A.M., and R. Van derMeer. 1993. The assumed assimilation of 
cholesterol by lactobacilli and Bi.fidobacterium bi.fidum is due to their salt-
deconjugating activity. Appl. Environ. Microbiol. 59: 1120. 
70. Kobashi, K., I. Nishizawa, and T. Yamada. 1978. ·Anew hydrolase specific for 
taurine-conjugates ofbile acids. J. Biochem. 84:495. 
71. Kolars, J.C., M.D. Levitt, M. Aoriji and D.A. Savaiano. 1984. Yogurt - an 
autodigesting source oflactose. N. Engl. J. Med. 310: 1. 
72. Kretchmer, N. 1972. Lactose and lactase. Sci. Am. 227:70. 
73. Kurmann, J.A., J.L. Rasic and M. Kroger. 1992. Encyclopedia of fermented fresh 
milk products. Vannostrand Reinhold. New York, New York. 
74. Lack, L. and I.M. Weiner. 1963. Intestinal absorption of bile salts and some 
biological implications. Fed. Prod. 22:1334. 
66 
75. Lin, S.Y., J.W. Ayres, W. Winkler, Jr., and W.E. Sandine. 1989. Lactobacillus 
effects on cholesterol: in vitro and in vivo results. I. Dairy Sci. 72:2885. 
76. Linc-Amster, H.F. Rochat, KY. Saudan, 0. Mignot, J.M. Aeschlimann. 1994. 
Modulation of a specific humoral immune response and changes in intestinal 
flora mediated through fermented milk intake. FEMS Immunol Med Microbiol. 
10:55. 
77. Lipid Research Clinics Program. 1984a. The lipid research clinics coronary primary 
prevention trial results. I. Reduction in incidence of coronary heart disease. J. 
Arn. Med. Assoc. 251:365 .. 
78. Lipid Research Clinics Program. 1984b. The lipid research clinics coronary primary 
prevention trial results. II. The relationship of reduction in incidence of 
coronary heart disease to cholesterol lowering. I. Arn. Med. Assoc. 251:365. 
79. Lundeen, S.G. and D.C. Savage. 1989. Purification of the Bile Salt Hydrolase from 
Lactobacillus sp strain 100-100. Abstract of the annual meeting of the American . 
Society for Microbiology. 
80. MacDonald, I.A., V.D. Bokkenheuser, I. Wi~ter, A.M. McLemon, and E.H. 
Musbach. 1983. Degradation of steroids in the human gut. I. Lipid Res. 
24:675. 
81. Mallory, A., F. Kem, I. Smith, an D. Savage. 1973. Patterns of bile acids and 
microflora in the human small intestine. Gastroenterology: 64:26. 
82. Maltseva, N.N., M.M. Shkarupeta, B,V. Pinegin, V.M. Korshunov. 1992. 
Immunomodulating properties of various microbes - representatives of normal 
intestinal microflora. Antibiot Khimioter. 37:41. 
83. Mann, C.V. and A. Spoerry. 1974. Studies of a surfactant and chlolesteremic in the 
Maasai. Arn J. Clin. Nutr. 27:464. 
84. Mann, C.V. 1977a. A factor in yogurt which lowers choleseremia in man. 
Arteriosclerosis. 26:335. 
85. Mann, C.V. 1977b. Hypocholesterolemic effect of milk. Lancet ii:556. 
86. Masuda, N. 1981. Deconjugation ofbile salts by Bacteroides and Clostridium. 
Microbiol. Immunol. 25: 1. 
87. McIntyre, N. and K.J. Isselbacher. 1973. Role of the small intestine in cholesterol 
metabolism. Arn. I. Clin. Nutr. 26:647. 
67 
88. Midvedt, T. and A. Norman. 1967. Bile acid transformations by microbial strains 
belonging to the genera found in intestinal contents. Acta. Pathol. Microbiol. 
Scand. 71:1341. 
89. Modler, H.W., RC. McKellar, and M. Yaguchi. 1990. Bifidobacteria and 
bifidogenic factors. Can. Inst. Food Sci. Technol. J. 23:29. 
90. Mott, G.E., RW. Moore, H. Redmond, and R reiser. D1973. Lowering of serum 
cholesterol by intestinal bacteria in cholesterol-fed piglets. Lipids. 8:428. 
91. Murotome, M., T. Watanabe, N. Suegara, Y. Kawai, and M. Mutai. 1975. 
Distribution of indigenous bacteria in the digestive tract of conventional and 
gnotobiotic rats. Infect. Immun. 11 :962. 
92. Nair, P.P., M. Gordon, and J. Reback. 1967. The enzymatic cleavage of the 
carbon-nitrogen bond in 3·, T, 12· Trihydroxy-5-Bcholan-24-oylglycine. J. Biol. 
Chem. 242:7. 
93. Newcomer, A.D., H.S. Park, P.C:.O'Brien and D.B. McGill. 1983. Response of 
patients with irritable bowel syndrome and lactase deficiency using unfermented 
acidophilus milk. Am. J. Clin. Nutr. 38:257. 
94. Nichols, M.A. 1978. Effect of a nonfermented milk inoculated with Lactobacillus 
acidophilus on lactose malabsorption; M.S. Thesis. Oklahoma State University. 
95. Nielson, J.W. and S.E. Gilliland. 1985. Variations in cholesterol assimilation by 
individual strains of Lactobacillus acidophilus and Lactobacillus casei from 
human intestines. J. Dairy Sci 68 (Supp. 1):83. 
96. Noh, D.O. and S.E. Gilliland. 1993. Influence of bile on cellular integrity and B-
galatosidase activity of Lactobacillus acidophilus. J. Dairy Sci. 76: 1253. 
97. Noh, D.O. 1991. Cholesterol uptake by Lactobacillus acidophilus: Its fate and 
factors influenceing the uptake. Ph.D. Dissertation. Oklahoma State University. 
98. Norman, A. and J. Sjovall. 1953. On the transformation and enterohepatic 
circulation of cholic acid in the rat. J. Physiol. 233: 872. 
99. Packard, C.J., and J. Shepherd. 1982. The hepatobiliary axis and lipoprotein 
metabolism: Effects of bile acid sequestrants and illeal bypass surgery. J. Lipid 
Res. 23: 1081. 
100. Papa, C.M., RD. McCarthy, A. Kilara, and G.A. Porter. 1980. Non-dialysable 
inhibitor of cholesterogenesis in bovine milk. J. Dairy Sci. 63 (Suppl. 1):42. 
68 
101. Patel, J.R., J.M. Dave and RI. Dave. 1992. Effect of feeding milk fermented with 
strains of lactobacilli on faecal lactobacilli and coliform counts in human test 
subjects. Indian J Dairy Sci. 45:379. 
102. Paul, R., C.S. Ramesha, and J. Ganguly. 1980. On the mechanism of 
hypocholesterolemic effect of polyunsaturated lipids. Adv. Lipid Res. 17;155. 
103. Pekkanen, J., S. Linn, G. Heiss, C.M. Suchindran, A. Leon, B.M. Rifkind, and H.A. 
Tyroler. 1990. Ten-year mortality from cardiovascular disease in relation to 
cholesterol level among men with and without pre-existing cardiovascular 
disease. N. Engl. J. Med. 322: 1700. 
104. Perdigon, G., M.E.N. Demacias, S. Alverez, G. Oliver and A.A.P.R. Holgado. 
1990. Prevention of gastrointestinal infection using immunobiological methods 
with milk fermented with Lactobacillus casei and Lactobacillus acidophilus. J. 
Dairy Res. 57:255. 
105. Playhoust, M.R. and K.J. Isselbacher. 1964. Studies on the transport and 
metabolism of conjugated bile salts by intestinal mucosa. 
106. Pozo-Olano,J. Dedioa, J.H. Warran Jr., R.G. Gomez and M.G. Cavazos. 1978. 
Effect of a lactobacilli preparation on traveler's diarrhea. Gastroenterol. 
74:829. 
107. Pulusani, S.R., and D.R. Rao. 1983. Whole body, liver and plasma cholesterol 
levels in rats fed Thermophilus, Bugaricus and Acidophilus milks. J. Food Sci. 
48:280. 
108. Rao, D.R., C.B. Chawan, and S.R. Pulusani. 1981. Influence of milk and 
Thermophilus milk on plasma cholesterol levels and hepatic cholesterogenesis in 
rats. J. Food Sci. 46:1339. 
109. Razin, S., S. Kutner, H. Efrati, and S. Rottem. 1980. Phospholipid and cholesterol 
uptake by mycoplasma cells and membranes. Biochim. Biophys. Acta. 598:628. 
110. Reilly, S.S. and S.E. Gilliland. 1996. Inhibition of Escherichia coli 0157:H7 by 
Lactobacillus acidophilus isolated from calves. 1997 Animal Science Research 
Report - Oklahoma State University. p. 47. 
111. Reynier, M.O., J.C. Montet, A. Gerolami, C. Marteau, C. Crotte, AM. Montet, and 
S. Mattieu. 1989. Comparative effect of cholic, chenodeoxycholic and 
ursodeoxycholic acid on micellar solubulization and intestinal absorption of 
cholesterol. J. Lipid Res. 22:467. 
112. Robins-Browne, RM., F.F. Path, and M.M. Levine. 1981. The fate ofingested 
lactobacilli in the proximal small intestine. Am. J. Clin. Nutr. 34:514. 
69 
113. Robinson, E.L. and W.L. Thompson. 1952. Effect on weight gain of the addition of 
Lactobacillus acidophilus to the formula of newborn infants. J. Pediatr. 41 :395. 
114. Rossouw, J.E., E. Burger, P. Van der Vyver, and J.J. Ferreira. 1981. The effect of 
skim milk, yogurt, and full cream milk on human serum lipids. Am. J. Clin. 
Nutr. 34:351. 
115. Rudel, L.L. and M.D. Morris. 1973. Determination of cholesterol using o-
phthalaldehyde. J. Lipid Res. 14: 364. 
116. Sako, K., H. Saito, H.Tomioka and T. Yokokura. 1988. Enhancement of host 
resistance against Listeria infection by Lactobacillus casei: Efficacy of cell wall 
preparation of Lactobacillus casei. Microbio. Immunology. 32: 1189. 
117. Sandine, W.E. 1979. Roles of Lactobacillus in the Intestinal Tract. J. Food Prot. 
42:259-262. 
118. SAS Institutelnc. 1985. SAS procedures guide for personal computers, version 6 
ed. Cary, NC: SAS Institute Inc. 
119. Savaiano, D.A., A. Abou Elanouar, D.E. Smith and M.D. Levitt. 1984. Lactose 
malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and 
cultured milk in lactase-de:ficient individuals. Am. J. Clin. Nutr. 40: 1219. 
120. Schiff, E.R., N.C. Small, and J.M. Dietschy. 1972. Characterization of the kinetics 
of the passive and active transport mechanisms for bile acid absorption in the 
small intestine and colon of the rat. J. Clin. Inves. 51: 13 51. 
121. Sellars, R.L. 1991. Acidophilus products. pp. 81-116. In RD. Robinson (ed). 
Therapeutic Properties of Fermented Milk. Elsevier Science Publishers LDT. 
Essex, England. 
122. Shiffrin, E.J., F. Rochat, H. Linc-Amster, J.M. Aeschlimann, A. Donnet-Hughes. 
1995. Immunomodulation of human blood cells following the ingestion oflactic 
acid bacteria. J Dairy Sci. 78:491. 
123. Shimuda, K., K.S. Bricknell, and S.M. Finegold. 1969. Deconjugation ofbile acids 
by intestinal bacteria: Review ofliterature and additional studies. J. Infect. Dis. 
119: 273. 
124. Shimuda, K., V.L. Sutter, and S.M. Finegold. 1970. Effect of bile and 
deoxycholate on Gram negative anaerobic bacteria. Appl. Microbiol. 20:737. 
70 
125. Shirota, Monoru. 1971. The summary of reports on Yakult. Yakult Honsha Co., 
LTD., 1:1-19. Higashi-Shinbashi, Minato-ku, Tokoyo, Japan. 
126. Silva, M., N.V. Jacobus, C. Denede and S.L. Gorbach. 1987. Antimicrobial 
substance from a human Lactobacillus strain. Antimicrobial Agents and 
Chemotherapy. 31: 1231. 
127. Smeianov, V.V., N.N Maltseva, W. Bossart, V.M. Korshunov. 1992. The effect of 
Lactobacillus acidophilus "Solco" on the immunological indices of totally 
decontaminated mice under complete gnotobiological isolation. Zh-Mikrobiol 
Epidemiol Immunobiol. 1992(11.;12):12. 
128. Somkuti, G.A., and T.L. Johnson. 1990. cholesterol uptake by Propionibacterium 
freudenreichii. Curr. Microbiol. 20:305. 
129. Stellwag, E.J. and P.B. Hylemon. 1976. Purification and characterization of bile 
salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta. 
452:165. 
130. Stryer, L. "Biosynthesis of Macromolecular Precursors". Biochemistry, 2°d Ed. 
Wilt Freeman and Co. San Francisco. 
131. Tannock, G.W., M.P. Dashkevicz, and S.D. Feighner. 1989. Lactobacilli and Bile 
Salt Hydrolase iri the Murine Intestinal Tract. ·· Appl. Environ. Microbiol. 
55:1848. 
132. Thakur, C.P. and A.N. Jha. 1981. Influence of milk, yoghurt and calcium on 
cholesterol-induced arteriosclerosis in rabbits. Arteriosclerosis .. 39:211. 
133. The National Heart and Lung Institute Taks Force on Arteriosclerosis. 1971. Vol. 
2. DREW Publication No. (NIH)72:219. 
134. Thompson, L.U., D.J.A. Jenkins, M.A. Vic Amer, R. Reichert, A. Jenkins, and J. 
Kamulsky. 1982. The effect of fermented and unfermented milks on serum 
cholesterol. Am. J. Clin. Nutr. 36: 1106. 
135. Van Belle, H. 1965. Cholesterol, Bile Acids and Atherosclerosis. North Holland 
Publishing Company. Amsterdam. 
136. Vanderzant, C., and D.F. Splittstoesser. (eds). 1992. Compendium of Methods for , 
the Microbial Examination of Foods, 3n1 ed. Washington, D.S. American 
Public Health Association. 
137. Voet, D. and J.G. Voet. 1995. Biochemistry, 2nd ed. John Wiley and Sons, Inc. 
New York, New York. pp. 662-726. 
71 
138. Walker, D.K., and S.E. Gilliland. 1993. Relationships among bile tolerance, bile salt 
deconjugation, and assimilation of cholesterol by Lactobacillus acidophilus. J. 
Dairy Sci. 76:956. 
139. Watkins, B.A. and B.F. Miller. 1983. Competitive gut exclusion of avian pathogens 
by Lactobacillus acidophilus in gnobiotic chicks. Poultry Sci. 62: 1772. 
140. Watkins, B.D., B.F. Miller, and D.H. Neil. 1982. In vivo inhibitory effects of 
Lactobacillus acidophilus against pathogenic Escherichia coli in gnobiotic 
chicks. Poult. Sci. 61:1298. 
141. Yasui, H. and M. Ohwake. 1991. Enhancement of immune response in Peyer' s 
patch cells cultured with Bifidobacterium breve. J Dairy Sci. 7 4: 1187. 
142. Yasui, H., J. Kiyoshima, H. Ushijima. 1995:, Passive protection against rotavirus-
induced diarrhea of mouse pups born to nursed by dams fed Bifidobacterium 
breve YIT4064. J. Infect Dis. ,172:403. 
143. Zacconi, C., V. Bottazzi, A. Rebecchi, R,Bosi, P.G. Sarra, and L. Tagliaferri. 1992. 
Serum cholesterol levels in axenic mice colonized with Enterocuccus f aecium 
and Lactobacillus acidophilus. Microbiologica. 15:413. 
72 
.APPENDIX A 
COMPREHENSIVE DATA SUMMARY 
73 
Table 4. Amount of cholesterol removed from MRS-THIO broth supplemented with 
10% cholesterol micelles and 6 mM sodium taurocholate by cultures grown at pH 6.0 and 
without pH control at 37°C. 
L. acidophilus 
Sample L. casei E51 L. caseiN19 43121 L. acidoE_hilus L 1 
Time EH:z NoEH2 EH No EH EH No EH EH No EH 
0 oa oa oa oa oa oa oa oa 
16 7.4a 17.6abcd 16.4abc 26.Scde 18.6bcd 46.3fghij 28.Scdef 26_7cde 
18 15.Sabc 41. lefghi 8.5abc 28.6cdefg 36.9defgh 58.3j 36.3defgh 38.6defgh 
20 8.0ab 56.6hij l0.4abc 3t5.3defgh 41.6efghi 60.& 46.9ghij 44.?efghij 
22 8.9ab 62.ii 13.6abc 46.8P'1ij 58.~ 67.<J 49.8ghij 57.8ij 
1 All values represent the mean from three trials, reported as ug cholesterol removed from 
broth; means showing the same superscript letter are not significantly (P>.05) different. 
Due to the nesting design of this experiment, standard errors have wider ranges when 
comparing two different cultures compared to standard errors within a single culture. 
2pH = pH maintained at 6.0; No pH= cultures grown without pH control 
74 
Table 5. Amount of sodium taurocholate deconjugated in MRS-TIIlO broth 
supplemented with I 0% cholesterol micelles and 6 mM sodium taurocholate by cultures 
grown at pH 6.0 and without pH control at 37°C. 
L. acidophilus 
Sample L. casei E51 L. caseiN19 43121 L. acido2.hilus LI 
Time EH2 NoeH2 EH NoeH EH NoeH EH NoeH 
0 oa oa oa oa oa oa oa oa 
16 2.3cd 2.lbc l.9bc 3.3ef 4.6hi 4.2hi I.Sb }.gbc 
18 4.6hi 3.3ef 3.4fg 2.9ef 4.6hi 4.1gb 1.7b 2.8de 
20 4.2gb 3.9gb 3.6fg 3_4fg 4.8i 4.8i 2.lc 4.1gb 
22 s.i 4_7'1i 3.6fg 3.5r8 4.6hi 4.8i 2.Sde 4.0gb 
1 All values represent the mean :from three: trials, reported as mM sodium taurocholate 
deconjugated :from broth; means showing the same superscript letter are not significantly 
(P>.05) different. Due to the nesting design of this experiment, standard errors have 
wider ranges when. comparing two different cultures compared to standard errors within a 
single culture. 
2pH = pH maintain~d at 6.0; No pH= cultures grown without pH control 
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Table 6. Plate counts of cultures grown at pH 6. 0 and without pH control in MRS-THIO 
broth supplemented with 10% cholesterol micelles and 6 mM sodium taurocholate 
L. acidophilus 
Sample L. casei E51 L. caseiNI9 43121 L. acidop_hilus LI 
Time EH:2 No~H2 EH No~H EH No~H EH No~H 
0 oa 0 oa 0 oa 0 oa 0 
16 9.59c 9.04c 9.03c 8.68c 9.26c 8.72c 8.67c 8.16ab 
18 9.58c · 8.69c 9.21c 8.63c 9.27c 8.59bc 8.70c 7.868 
20 9.77c 8.56bc 9.21c 8.62c 9.35c 8.36bc 8 .. 84c 7.99ab 
22 9.74c 8.33abc 9.26c 8.68c 8.99c .s.1sabc 8.63c 8.25abc 
1 All values represent the mean from three trials, reported as Log10 cfu/ml; means showing 
the same superscript letter are not significantly (P>. 05) different. Due to the nesting 
design of this experiment, standard errors have wider ranges when comparing two 
different cultures compared to standard errors within a single culture. 
2pH = pH maintained at 6.0; No pH= cultures grown without pH control 
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Table 7. pH ofMRS-THIO broth supplemented with 10% cholesterol micelles and 6 
mM sodium taurocholate during growith of cultures at pH 6.0 and without pH control at 
31°c. 
casei E5 1 
L. acidophilus 
Sample L. L. caseiN19 43121 L. acidol!._hilus L 1 
Time EH:2 NoEH2 EH No EH EH No EH EH No EH 
0 6.5a 6.5a 6.5a 6.5a 6.5a 6.5a 6.5a 6.5a 
16 6b 4.2gb 6b 4.3fg 6b 4.4ef 6b 4.7c 
18 6b 4.2gb 6b 4.2gb 6b 4.4ef 6b 4.6cd 
20 6b 4.2gb 6b 4.2gb 6b 4.i8 6b 4.6cd 
22 6b 4:lh 6b 4.2gb 6b 4.2gb 6b 4.5d 
1 All values represent the mean from three trials, reported as pH of broth; means showing 
the same superscript letter are not significantly (P>.05) different. Due to the nesting 
design of this experiment, standard errors have wider ranges when comparing two 
different cultures compared to standard errors within a single culture. 
2pH = pH maintained at 6.0; No pH= cultures grown without pH control 
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Table 8. Amount of sodium glychocholate and sodium taurocolate deconjugated by L. 
casei during growth with and without pH control at 3 7°C in MRS-TIIlO broth 
supplemented with 1.2 mM sodium taurocholate and 3.8 mM glychocolic acid 
Sodium Taurocholate Sodium Gl~chocolate 
Sample L. caseiES L. caseiNl9 L. caseiES L. caseiNl9 
Time :eH No:eH :eH No:eH :eH No~H :eH No:eH 
16 .27bc .42c .07a .07a l.Scd 2.1 e l.Oab .48a 
18 .56cd .86d .09a .07a 2. lcde 2.8e l.3bc l.2ab 
20 .75d .88d .19ab .16ab 2.8e 2.8e l.7cd I.lab 
22 .68cd .sod .49cd .27bc 2.8e 2.8e 2.4de .98ab 
1 All values represent the mean from three trials, reported as mM deconjugated/ml ; means 
showing the same superscript letter are not significantly (P>.05) different. Due to the 
nesting design of this experiment, standard errors have wider ranges when comparing two 
different cultures compared to standard errors within a single culture. 
2pH = pH maintained at 6.0; No pH= cµltures grown without pH control 
78 
APPENDIXB 
RAWDATAFROMTREATMENTS 
79 
TABLE9 
Plate Counts on MRS agar of cells of Lactobacillus casei E5 Grown with no pH Control 
at 37°C in MRS-THIO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 9.04 9.08 8.99 9.04 
18 8.75 8.57 8.75 8.69 
20 8.82 8.41 8.46 8.56 
22 8.85 8.32 7.83 8.33 
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TABLE 10 
Plate Counts on MRS agar of .cells of Lactobacillus casei E5 Grown at pH 6. 0 at 3 7°C in 
MRS-TIIlO Broth Supplemented with 3% Sodium Taurocholate and 10% Cholesterol 
Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 Rep2 Rep3 . Average 
16 9.91 9.88 8.18 9.59 
18 . 8.86 9.72 8.76 9.58 
20 9.93 · 9.86 8'.88 9.77 
22 9.86 9.88 8.79 9.74 
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TABLE 11 
Plate Counts on MRS agar of cells of Lactobacillus casei N19 Grown with no pH Control 
at 37°C in MRS-TlllO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 . Rep2 Rep3 Average 
16 8.64 8.41 9.00 8.68 
18 8.56 8.41 8.93 8.63 
20 8.59 8.41 8.85 8.62 
22 8.76 8.38 8.90 8.68 
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TABLE 12 
Plate Counts on MRS agar of cells of Lactobacillus casei Nl9 Grown at pH 6.0 at 37°C 
in MRS-THIO Broth Supplemented with 3% Sodium Taurocholate and 10% Cholesterol 
Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 9.59 9.32 9.00 9.03 
18 9.54 · 9.32 9.15 9.21 
20 9.41 9.34 9.52 9.21 
22 9.65 9.34 9.48 9.26 
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TABLE 13 
Plate Counts on MRS agar of cells of Lactobacillus acidophilus 43121 Grown with no 
pH Control at 37°C in MRS-TIIlO Broth Supplemented with 3% Sodium Taurocholate 
and 10% Cholesterol Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 8.67 8.77 8.72 8.72 
18 8.59 8.71 8.48 8.59 
20 · 8.20 8.59 8.28 8.36 
22 7.08 9.15 8.32 8.18 
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TABLE 14 
Plate Counts on MRS agar of cells of Lactobacillus acidophilus 43121 Grown at pH 6.0 
at 37°C in MRS-THIO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 9.11 9.28 9.38 9.26 
18 9.08 9.04 9.67 9.27 
20 9.08 9.38 9.58 9.35 
22 9.20 8.43 9.34 8.99 
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TABLE 15 
Plate Counts on MRS agar of cells of Lactobacillus acidophilus LI Grown without pH 
control at 3 7°C in MRS-THIO Broth Supplemented with 3% Sodium Taurocholate and 
10% Cholesterol Micelles 
Log 10 cfu/ml 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 9.11 9.00 7.89 8.67 
18 9.17 9.04 7.98 8.70 
20 9.15 9.18 8.15 8.84 
22 9.20 9.23 7.46 8.63 
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TABLE 16 
Amount of cholesterol removed fromMRS-THIO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei E5 grown with no pH 
control at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 28.98 7.73 15.93 
18 46.44 28.21 48.56 
20 .. 76.0 ,'41.65 52.01 
22 83.29 "44.14 49.30 
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TABLE17 
Amount of cholesterol removed from MRS-TIIlO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei E5 grown at pH 6.0 
at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.88 5.57 17.08 7.36 
18 2.88 9.47 14.00 15.5 
20 5:88 8.64 6.52 7.97 
22 . l 1.33 10.94 13.82 8.36 
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TABLE 18 
Amount of cholesterol removed from MRS-TIBO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei Nl9 grown with no 
pH control at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 16.89 49.33 13.24 26.49 
18 21.12 32.63 32.05 28.6 
20 22.65 54:51 31.67 36.28 
22 39.35 57.39 43.57 46.76 
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TABLE19 
Amount of cholesterol removed from MRS-THIO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei N19 grown at pH 6.0 
at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 9.22 23.03 13.63 16.44 
18 1.54 9.98 34.16 8.51 
20 1.34 23.42 9.40 10.43 
22 8.64 18.43 4.61 13.63 
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TABLE20 
Amount of cholesterol removed from MRS-TIIlO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus 43121 grown 
with no pH control at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 28.4 43.95 66.59 46.31 
18 55.66 45.87 73.51 58.35 
20 58.34 51,43 71.97 60.58 
22 . 75.62 55.28 73.13 67.98 
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TABLE21 
Amount of cholesterol removed from MRS-THIO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus 43121 grown at 
pH 6.0 at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 27.25 13.82 14.78 18.62 
18 36.08 27.83 46.25 36.89 
20 50,28 29.44 44.53 41.58 
22 62.95 54.89 57.58 58.47 
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TABLE22 
Amount of cholesterol removed from MRS-TIDO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus LI grown with 
no pH control at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 21.88 26.3 31.88 26.69 
18 26.87 50.09 38.77 38.58 
20 34.35 69.1 30.71 44.72 
22 48.79 75.43 49.14 57.79 
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TABLE23 
Amount of cholesterol removed from MRS-THIO Broth Supplemented with 3% Sodium 
Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus 43121 grown at 
pH 6.0 at 37°C. 
ug cholesterol removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 4.19 61.23 20.15 28.52 
18 17.47 62.19 29.18 36.28 
20 35.69 63.92 41.08 46.89 
22 32.63 65.65 51.06 49.78 
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TABLE24 
Amount of sodium taurocholate removed from MRS-THIO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei ES grown 
with no pH control at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep 2 Rep 3 Average 
16 3.06 2.06 1.05 
18 4.97 2.65 2.29 
20 5.26 3.08 3.56 
22 5.40 4.24 4.34 
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TABLE25 
Amount of sodium taurocholate removed from MRS-TIIlO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei ES grown at 
pH 6.0 at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 1.95 1.65 1.25 2.29 
18 4.22 4.47 3.16 4.59 
20 4.22 3.71 4.75 4.17 
22 ·4.33 4.76 5:00 5.16 
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TABLE26 
Amount of sodium taurocholate removed from MRS-TIDO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei N19 grown 
with no pH control at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.98 3.69 3.16 3.28 
18 3.08 2.55 3.18 2.94 
20 2.80 3.39 3.92 3.37 
22 2.95 3.83 4;09 3.53 
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TABLE27 
Amount of sodium taurocholate removed from MRS-TRIO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus casei N19 grown at 
pH 6.0 at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 3.06 1.36 3.29 1.89 
18 2.99 4.41 2.90 3.44 
20 3.04 4.26 3.37 3.56 
22 , 3.17 4.13 3.44 3.58 
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TABLE28 
Amount of sodium taurocholate removed from MRS-THIO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus 43121 
grown with no pH control at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 4.00 4.79 3.91 4.24 
18 4.31 3.93 4.05 4.09 
20 4.98 5.29 4.05 4.78 
22 4.53 4.84 5.17 4.84 
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TABLE29 
Amount of sodium taurocholate removed from MRS-THIO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilusi 43121 
grown at pH 6.0 at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 4.16 5.39 4.35 4.63 
18 3.86 5.34 4.49 4.57 
20 4:91 5.16 4.36 4.81 
22 5.00 4.29 4.36 4.55 
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TABLE30 
Amount of sodium taurocholate removed from MRS-THIO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus Ll 
grown with no pH control at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.43 2.15 1.14 1.91 
18 3.58 2.39 2.43 2.79 
20 3.76 4.61 3.78 4.05 
22 3.74 4.74 3.63 4.03 
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TABLE 31 
Amount of sodium taurocholate removed from MRS-TIDO Broth Supplemented with 3% 
Sodium Taurocholate and 10% Cholesterol Micelles by Lactobacillus acidophilus Ll 
grown at pH 6.0 at 37°C. 
mM Sodium Taurocholate removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 1.46 1.05 2.21 1.14 
18 1.71 1.15 1.54 2.43 
20 2.11 1.05 1.49 3.78 
22 2.46 1.78 1.98 
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TABLE32 
pH of MRS-TRIO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles after growth of Lactobacillus casei ES at 37°C. 
H 
Harvest Time Rep 1 Rep2 Rep3 Average 
0 6.5 6.5 6.5 6.5 
16 4.2 4.2 4.2 4.2 
18 4.2 4.2 4.2 4.2 
20 4.2 4.2 4.2 4.2 
22 4.2 4.0 4.2 4.1 
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TABLE33 
pH of MRS-TIIlO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles after growth of Lactobacillus casei N19 at 37°C. 
H 
Harvest Time Rep 1 Rep2 Rep3 Average 
0 6.5 6.5 6.5 6.5 
16 4.3 4.5 4.2 4.3 
18 4.3 4.4 4.0 4.2 
20 4.2 4.4 4.0 4.2 
22 4.2 4.4 4.0 4.2 
._,,.: ... 
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TABLE34 
pH of MRS-THIO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles after growth of Lactobacillus acidophilus 43121 at 37°C. 
H 
Harvest Time Rep 1 Rep2 Rep3 Average 
0 6.5 6.5 6.5 6.5 
16 4.3 4.4 4.4 4.4 
18 4.3 4.4 4.3 4.4 
20 4.3 4.3 4.3 4.3 
22 4.2 4.2 4.2 4.2 
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TABLE35 
pH of MRS-TRIO Broth Supplemented with 3% Sodium Taurocholate and 10% 
Cholesterol Micelles after growth of Lactobacillus acidophilus 43121 at 37°C. 
H 
Harvest Time Rep 1 Rep2 Rep3 Average 
0 6.5 6.5 6.5 6.5 
16 4.8 4.6 4.6 4.7 
18 4.8 4.5 4.5 4.6 
20 4.8 4.5 4.5 4.6 
22 4.8 4.3 4.3 4.5 
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TABLE36 
Amount of sodium taurocholate from MRS-TIIlO Broth Containing 3.8 mM sodium 
taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei ES grown with no pH 
control at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .45 1.74 1.8 1.33 
18 3.15 J.77 3.3 2.74 
20 3.08 2.02 3.3 2.8 
22 3.09 2.38 2.99 2.82 
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TABLE37 
Amount of glychocolic acid removed from MRS-TRIO Broth Containing 3. 8 mM 
sodium taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei E5 grown with 
no pH control at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.2 2.2 1.81 2.07 
18 2.2 2.2 2.2 2.2 
20 2.2 2.2 2.2 2.2 
22 2.2 2.2 2.2 2.2 
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TABLE38 
Total bile salts removed from MRS-THIO Broth Containing 3.8 mM sodium taurocholate 
and 2.2 mM glycocholic acid by Lactobacillus casei ES grown with no pH control at 
31°c. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.65 3.94 3.61 3.40 
18 5.35 3.97 5.50 4.94 
20 5.28 ·4.22 5.50 5.00 
22 5.29 4.58' 5.17 5.01 
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TABLE39 
Amount of sodium taurocholate removed from MRS-THIO Broth Containing 3 .8 mM 
sodium taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei E5 grown at 
pH 6.0 at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .77 1.05 .84 0.87 
18 2.18 1.29 1.82 1.76 
20 1.75 1.24 2.07 1.69 
22 · 1.89 2.04 2.6 2.18 
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TABLE40 
Amount of glychocolic acid removed from MRS-THIO Broth Containing 3. 8 mM 
sodium taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei ES grown at 
pH 6.0 at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.2 1.65 1.49 1.78 
18 2.2 1.85 2.2 2.08 
20 2.2 2.2 2.2 2.2 
22 2.2 2.2 2.2 2.2 
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TABLE41 
Total bile salts removed from MRS-TIIlO Broth Containing 3.8 mM sodium taurocholate 
and 2.2 mM glycocholic acid by Lactobacillus casei ES grown at pH 6.0 at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 2.97 2.7 2.33 2.67 
18 4.38 3.14 4.02 3.85 
20 3.95 3.44 4.27 3.85 
22 4.09 4.24 4.8 4.38 
112 
TABLE42 
Amount of sodium taurocholate from MRS-TRIO Broth Containing 3. 8 mM sodium 
taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei Nl9 grown with no pH 
control at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .27 .18 0 0.23 
18 .26 .44 0 0.23 
20 .25 1.27 0 0.51 
22 .13 1.6 .85 0.86 
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TABLE43 
Amount of glychocolic acid removed from MRS-TRIO Broth Containing 3. 8 mM 
sodium taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei N19 grown 
with no pH control at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .53 .62 0 .38 
18 .79 1.05 0 0.92 
20 .57 1.24 .72 0.84 
22 .77 1.33 .23 0.78 
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TABLE44 
Total bile salts removed from MRS-THIO Broth Containing 3.8 mM sodium taurocholate 
and 2.2 mM glycocholic acid by Lactobacillus casei NI 9 grown with no pH control at 
31°c. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .8 .8 0 0.53 
18 1.05 1.49 0 0.85 
20 .82 2.6 1.55 2.49 
22 .9 2.84 .4 1.38 
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TABLE45 
Amount of sodium taurocholate removed from MRS-THIO Broth Containing 3. 8 mM 
sodium taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei N19 grown at 
pH 6.0 at 37°C. . 
mM bile salt removed :from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .33 0 0 0.11 
18 .38 .05 0 0.14 
20 .28 .62 0 0.31 
22 1.24 .24 .85 0.78 
116 
TABLE46 
Amount of glychocolic acid removed from MRS-THIO Broth Containing 3. 8 mM 
sodium taurocholate and 2.2 mM glycocholic acid by Lactobacillus casei Nl9 grown at 
pH 6.0 at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .61 .61 0 0.41 
18 .71 .82 0 0.51 
20 .88 1.04 0 0.96 
22 .89 .70 .44 0.68 
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TABLE47 
Total bile salts removed from MRS-THIO Broth Containing 3.8 mM sodium taurocholate 
and 2.2 mM glycocholic acid by Lactobacillus casei ES grown at pH 6.0 at 37°C. 
mM bile salt removed from broth 
Harvest Time Rep 1 Rep2 Rep3 Average 
16 .94 .87 0 0.60 
18 1.09 1.66 0 0.92 
20 1.16 .94 0 0.70 
22 2J3 .61 1.29 1.34 
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APPENDIXC 
IDENTITY OF ISOLATES OF L. CASE! 
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TABLE49 
IDENTITY OF ISOLATES OF LACTOBACIUUS CASE! 
Test1 Lc2 A3 .·A17 E5 ElO L15 L19 M5 M12 N7 N19 
Amygdalin + + ·+ + + + + 
- -
+ +/-
Arabinose 
-
+/- + + 
Arginine 
- - - - -
+ 
Cellobiose + + + + + + + + + + + 
Esculin + + + + + + + + + + + 
Galactose + + + + + + + + + + + 
Glucose + + + + + + + + + + + 
Lactose + + + + + + + + +/-
Maltose +/- + + + + + + + +/- +/- + 
Mannitol + + + + + + + + + + + 
Mannose + + + + + + + + + + + 
Melezitose + + + + + +/- + + ·+ + + 
.... 
Melibiose 
-
+ + - + 
1-J Raffinose - +/- +/- - +/-0 
Rhamnose 
- -
- . 
- - - -
+ + + 
Salicin + + + + + + + + + + + 
Sorbitol + + + + + + + + + 
Sucrose +/- + + + + + + + +/-
Trebalose + + + + + + + + + + + 
Xylose 
-
+/-
Growth at 45°C + - + + - - + + + + 
1 All isolates were Gram positive, catalase negative rods which grew at 15 °C. . 
2Lc = Lactobacillus casei; reactions as listed in the 8th Edition of Bergey 's Manual of Determinative Bacteriology. 
APPENDIXD 
EXPERIMENTAL DESIGN 
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EXPERIMENTAL DESIGN 
DF 
Total 119 
Among Broth Mix 11 
Culture 5 
Error a 8 
Within Broth Mix 12 
Treatment 1 
TxC 3 
Errorb 8 
Among Time 96 
Time 4 
Tix Tr 4 
Trx Culture 12 
Ti x Tr Culture 12 
Error c 64 
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